Exhibit 10.5


 


 


Master Purchase Agreement


 


This Master Purchase Agreement (this “Agreement”),
effective as of
                    ,
2008 (the “Effective Date”), is entered into
between Applera Corporation, a Delaware corporation (“AB”),
having a place of business at 850 Lincoln Centre Drive, Foster City, California
94404, and Celera Corporation, a Delaware Corporation (“Celera”),
having a place of business at 1401 Harbor Bay Parkway, Alameda, California
94502, each individually a “Party” and
collectively the “Parties”.


 


WHEREAS, Celera desires to purchase certain products from AB, and AB,
subject to the terms and conditions of this Agreement, is willing to supply
such products to Celera;


 


NOW, THEREFORE, in consideration of the premises and mutual promises set
forth in this Agreement, the Parties agree as follows:


 


1                                         Definitions


 


1.1.        “Celera Critical Product” means a Product to be supplied by
AB to Celera pursuant to this Agreement that (i) as of the Effective Date
is manufactured by AB or for AB using AB’s IPR, (ii) is used by Celera in
the manufacture or sale of Celera Products as of the Effective Date, (iii) will
be used in Celera’s breast cancer products in development as of the Effective
Date and (iv) (x) for which IPR, owned or controlled by AB, would be
required if Celera were to make or have made such Celera Products or (y) where
there is no commercially reasonable alternative to AB as a source of supply. Products
shall be designated as Celera Critical Products by the Parties prior to the
Effective Date. In addition, Celera Critical Products will include Products
derived from the Maui Project that are used by Celera in the manufacture or
sale of Celera Products and that are manufactured by AB or for AB using AB’s
IPR and as to which clause (iv) above is applicable.


 


1.2.        “Celera Product” means a product made by or on behalf of
Celera, that is sold by Celera or its Distributor, that contains an
Intermediate purchased from AB and/or an Oligonucleotide Conjugate purchased
from AB or manufactured by or for Celera.


 


1.3.        “Defective Item” means a Product that has a manufacturing
defect or design defect under the product liability laws of the State of
Delaware.


 


1.4.        “Diagnostic Losses” means claims, losses, damages, expenses
or liabilities arising from or caused by, or alleged to have arisen from or be
caused by, any failure of a Celera Product or any component or part thereof, to
properly diagnose a disease or condition or to make a diagnosis, including
without limitation the making or reporting by a Celera Product or any component
or part thereof of an incorrect diagnosis or a false positive finding or
indication, or the failure of a Celera Product or any part or component thereof
to make or report a finding or indication that if made would result in or
support a diagnosis.


 


1.5.        “Distributor” means any distributor of Celera Products for
Celera. A Distributor of Celera Products as of the Effective Date is Abbott
Molecular.


 


1.6.        “Effective Date” means the date set forth in the preamble
above.


 


[***] indicates material that
has been omitted pursuant to a request for confidential treatment. The omitted
material has been filed separately with the Securities and Exchange Commission.


 


1

















 


 


1.7.        “Field” means Human In Vitro Diagnostics Field as defined in
the Separation Agreement.


 


1.8.        “Intellectual Property Rights” or “IPR”
means all intangible property rights worldwide arising under statutory or
common law, whether or not perfected, including, without limitation, all (1) patents,
patent applications and patent rights; (2) divisions, continuations,
continuations-in-part, renewals, reissues, re-examinations, continuing
prosecutions, and extensions of the foregoing existing at a time in question,
or thereafter filed, issued or acquired; (3) rights associated with works
of authorship including copyrights, copyright applications, copyright
registrations, and derivative works; and (4) Know-how.


 


1.9.        “Instrument” means an Applied Biosystems CE sequencer
instrument previously purchased by Celera or Abbott for the Abbott Alliance (as
defined in the Operating Agreement) as listed on Exhibit B attached
hereto.


 


1.10.      “Intermediate” means the materials that are sold by AB,
including AB catalog products and materials that were produced and/or
configured on a custom basis for Celera and any New Products that are added,
but excluding Raw Materials, that are listed in Exhibit A.1.


 


1.11.      “Know-how” means confidential and/or proprietary technical
and other information, whether patentable or not, including, without
limitation, concepts, discoveries, inventions, modifications, improvements,
data, results, designs, formulae, ideas, analyses, methods, techniques, assays,
research plans, procedures, tests, processes (including manufacturing processes,
specifications and techniques), laboratory records, chemical, pharmacological,
toxicological, clinical, analytical and quality control data, reports, and
summaries.


 


1.12.      “Knowledge”
means, and is limited to, the actual knowledge, as of the Effective Date, of a
Party’s Named Representatives, of facts, documents or information, without
investigation on the part of such Named Representatives. Knowledge may not be
imputed, and there shall be no duty to conduct further inquiry, from the fact
that particular documents, contracts, patents, licenses or the like
(collectively, “document files”) are possessed by a Party’s Named
Representatives, where such Named Representatives have not investigated such
document files.


 


1.13.        “Named Representative” means, with respect to AB, the patent
attorneys and patent agents, senior director attorneys and technology
transaction attorneys in the Applied Biosystems Legal Department and the Senior
Director of Strategic Technology Licensing in the Applied Biosystems Strategy
and Business Development Department, and, with respect to Celera, any officer
or employee.


 


1.14.      “New Product” means a product to be supplied by AB to Celera
that is not listed on Exhibit A as of the Effective Date.


 


1.15.      “New Product Pricing” means the price assigned to a New
Product at the time such New Product is added to the list of Products on Exhibit A
and any New Product derived from the Maui Project (as defined in the Operating
Agreement). For AB products in existence at the time such AB product becomes a


 


[***] indicates material that
has been omitted pursuant to a request for confidential treatment. The omitted
material has been filed separately with the Securities and Exchange Commission.


 


2

















 


 


New Product by its addition to Exhibit A
and any New Product derived from the Maui Project, New Product Pricing will be
established using a trailing 12 month weighted average of the sales price, less
customary trade discounts and allowances and excluding in all cases, sales to
Celera and sales involving promotional or early access discounts or special
pricing as part of a collaborative exchange with a Third Party (all of the
foregoing collectively, “net sales price”) to AB’s top five customers (or a
smaller number if there are less than five customers) receiving the lowest
global net sales price for such New Products (“AB’s Top
Five”).


 


If the New Product has not been previously sold by AB at the time such
AB product is to become a New Product, the initial sales price to Celera will
be based on AB’s established list price for such New Product less a discount of
10%. An interim New Product Pricing will be determined using the weighted
average of the net sales price to AB’s Top Five for the next 2 full AB fiscal
quarters following the addition of the New Product to Exhibit A and any
New Product derived from the Maui Project A final New Product Pricing will be
determined using the weighted average of the net sales price to AB’s Top Five
for the next four full AB fiscal quarters following the determination of the
interim New Product Pricing. Such final New Product Pricing will be effective
immediately thereafter for 1 full fiscal year, subject to the provisions of
Sections 5.2 and 5.3. In no event will retroactive adjustments be made for any
sales from AB to Celera using the initial sales price for a New Product.


 


1.16.      “Oligonucleotide Conjugate” means an oligonucleotide that
has been chemically combined with a Raw Material.


 


1.17.      “Products” means Intermediates and Raw Materials listed on Exhibit A.1
(Intermediates) and on Exhibit A.2 (Raw Materials), respectively, and
Instruments on Exhibit B, including any New Products added thereto
subsequent to the Effective Date.


 


1.18.      “Raw Materials” means materials that are not sold by AB as
standalone products or as components of products but that are used by AB to
make Oligonucleotide Conjugates and other chemical derivatives of such
materials. Raw Materials include those that are listed in Exhibit A.2, and
any New Products that are Raw Materials and are added to Exhibit A.2.


 


1.19.      “Separation Agreement” means the agreement between AB and
Celera dated May 8, 2008. Capitalized terms used but not defined in this
Agreement will have the meaning given to such terms in the Separation
Agreement.


 


1.20.      “Specifications” means, with respect to a Product listed on Exhibit A
or Exhibit B as of the Effective Date, AB’s written specifications for
such Product or, if there are no written specifications for a Product,
specifications agreed to in writing by the Parties.


 


1.21.      “Third Party” means any person or entity other than Celera
or AB or an Affiliate of Celera or AB.


 


1.22.      “Third Party Manufacturer” means a Third Party that is a
contract manufacturer for a Party. For the avoidance of doubt, a Third Party
Manufacturer does not include a Third Party who supplies a Party with products
or materials according to the specifications of that Third Party.


 


[***] indicates material that has been omitted pursuant to a request
for confidential treatment. The omitted material has been filed separately with
the Securities and Exchange Commission.


 


3

















 


2                                         Products


 


2.1.        Product List. Subject to the terms and conditions of this
Agreement, AB will use commercially reasonable efforts to deliver to Celera or
Distributor, as ordered by Celera pursuant to this Agreement, the Products
listed on and further described in Exhibits A.1 and A.2, at prices to be
determined by the Parties prior to the Effective Date based on historical
prices, and Exhibit B, attached hereto.


 


2.2.        Adding Products. From time to time, New Products may be
added to Exhibits A or B, at which time such New Products will become subject
to the terms of this Agreement.


 


(a)       If
a New Product is offered by AB to its customers, then 30 days after Celera’s
written request, such New Product will be added to Exhibit A, subject to Section 2.8,
at the New Product Price. In the event that AB must pay a royalty to a Third
Party in order to sell such New Product to Celera pursuant to this Agreement,
and such royalty is not already included in the New Product Price, the amount
of such royalty due with respect to a sale of such New Product by Celera will
be paid by Celera to AB (defined herein as a “Pass-Through
Royalty”). The New Product Price and any applicable Pass-Through
Royalty will be determined by AB within 30 days of such New Product being added
to Exhibit A. For the avoidance of doubt, no Pass-Through Royalty will be
applicable to Products listed on Exhibit A as of the Effective Date to the
extent AB has breached its representations and warranties set forth in Section 2.8
with respect to such Products.


 


(b)      Notwithstanding
Section 2.2(a) above, if Celera can demonstrate that it has
previously ordered a product that is not listed on Exhibit A, such product
will be added to Exhibit A, subject to Section 2.8, at the price
previously paid by Celera, as adjusted pursuant to Section 5.2, and will
be deemed a Product hereunder as of the Effective Date.


 


(c)       If
a New Product is not offered by AB to its customers at the time of Celera’s
request, such New Product will be deemed a custom product and will be addressed
as described in Section 2.7.


 


(d)      If
a New Product is derived from the Kauai Project (as defined in the Operating
Agreement) it will be added to Exhibits A or B, as the case may be, at a price
determined as set forth in the agreement between the Parties for the Kauai
Project.


 


(e)       If
a New Product is derived from the Maui Project it will be added to Exhibits A
or B, as the case may be, at the New Product Price. In the event that AB must
pay a royalty to a Third Party in order to sell such New Product to Celera
pursuant to this Agreement, and such royalty is not already included in the New
Product Price, the Pass-Through Royalty will be paid by Celera to AB. The New
Product Price and any applicable Pass-Through Royalty will be determined by AB
within 30 days of such New Product being added to Exhibit A.


 


(f)       If
a New Product is an Instrument and is not covered by clauses (d) and (e) above,
it will be added to Exhibit B at a price agreed to by the Parties.


 


2.3.        Removing Products. AB will be able to remove Products from Exhibit A
or B if AB ceases to manufacture Products and/or have manufactured for it
Products using AB’s IPR.


 


[***] indicates material that
has been omitted pursuant to a request for confidential treatment. The omitted
material has been filed separately with the Securities and Exchange Commission.


 


4

















 


 


AB will give
Celera six months prior written notice of the date of removal, provided that if
AB is legally compelled to withdraw a product no prior notice need be given,
but notice will be given to Celera as soon as practicable thereafter, and
further provided that if a Third Party Manufacturer ceases manufacture of a
Product it supplies to AB, AB need only provide the notice period it receives
from such Third Party Manufacturer. AB will afford Celera an opportunity to
make an “end of life” purchase of such Product, provided a purchase order for
same is received within 30 days after delivery of written notice of proposed
discontinuance to Celera. Such end of life purchase will not exceed the volume
of that Product Celera estimates it will need for the following two years. AB
will use commercially reasonable efforts to manufacture, or have manufactured,
and deliver the amount of such Product ordered by Celera.


 


2.4.        Celera’s Right to Continue Production. In the event AB
elects to remove a Celera Critical Product from Exhibit A or is prevented
from supplying a Celera Critical Product due to a Force Majeure Event (as
defined in Section 22.6) applicable to AB that continues for 60 days
beyond the delivery date for such Celera Critical Product, AB will have the option
of (i) securing an alternative source of
supply for such Celera Critical Product, subject to
Celera’s approval, such approval not to be unreasonably withheld or delayed, or (ii) granting Celera the right to
manufacture such Celera Critical Product itself or through a Third Party
Manufacturer selected by Celera, subject to AB’s approval, such approval not to be
unreasonably withheld or delayed. Notwithstanding anything to contrary herein,
AB will not be obligated to transfer any IPR to Celera or a Third Party
Manufacturer if AB is prohibited from doing so by an injunction. Any
alternative source of supply of a Celera Critical Product to Celera pursuant to
clause (i) above will be on terms substantially similar with the terms of
this Agreement, including price. Celera’s supply through a Third Party
Manufacturer pursuant to clause (ii) above will be subject to the
representations set forth in Section 2.8.


 


If Celera is granted the
right to manufacture the Celera Critical Product itself as provided herein or
through a Third Party Manufacturer, AB will in a timely manner (as is reasonable under
the circumstances) grant to Celera a limited,
non-exclusive, royalty-free license, subject to Section 2.8, (without the
right to sublicense or transfer except as provided herein) to use Intellectual
Property Rights owned or controlled by AB necessary to enable Celera or the
approved Third Party Manufacturer to manufacture the Celera Critical Product.
AB will also provide  technical, product and
manufacturing documentation that Celera or the Third Party Manufacturer may
request as is reasonably necessary to allow Celera continued supply of the
Celera Critical Product so that the availability of the Celera Critical Product
is not interrupted or any interruption is minimized. In addition, any
additional assistance, such as training, that Celera or the Third Party
Manufacturer requests will be provided at AB’s then prevailing rates. Celera
will require any Third Party Manufacturer to agree in writing to treat AB’s
technical, product and manufacturing documentation and Intellectual Property
Rights as Confidential Information of AB, and Celera will restrict disclosure
to those employees and contractors to whom it is necessary to disclose such
Confidential Information in connection with the performance of the duties under
this Section 2.4.


 


AB may notify and demonstrate to Celera that it is again willing and
able to supply the Celera Critical Product. Upon such notice from AB, Celera
will, in a time frame that is commercially reasonable under the circumstances,
commence purchasing the Celera Critical Product from AB and Celera’s rights
under this Section 2.4 will terminate.


 


[***] indicates material that
has been omitted pursuant to a request for confidential treatment. The omitted
material has been filed separately with the Securities and Exchange Commission.


 


5

















 


 


2.5.        Intermediates and Components for Further Manufacturing


 


(a) Intermediates.  Subject
to the restrictions and obligations on Celera’s use of the Intermediates set
forth in this Agreement, Celera will sell Intermediates, directly or through a
Distributor, only (i) to end users who purchase or use Celera diagnostic
products and (ii) for use only with Celera diagnostic products. For the
avoidance of doubt, the foregoing will not restrict Celera’s or its bona fide
collaborators’ use of Intermediates for research, development or in Celera’s
clinical laboratory testing services business, subject in each case to the
restrictions and obligations on Celera herein.


 


(b) Components for Further
Manufacturing. Intermediates and Raw Materials will be deemed to be
and will be components for further manufacturing, and Celera will be deemed to
be and will be the finished device manufacturer, or the manufacturer of any
Celera Product that is a diagnostic product, within the meaning of the U.S.
Food and Drug Administration (“FDA”) laws, rules and
regulations and foreign laws, rules and regulations governing the
manufacture, sale and distribution of diagnostic and other medical devices. AB
may label or refer to Intermediates and Raw Materials as components for further
manufacturing. In the event that any Intermediate or Raw Material is
accompanied by a label or statement stating that such Intermediate or Raw
Material is “For Research Use Only. Not for use in diagnostic procedures” or
words of the same import, such label will not be deemed to restrict Celera’s
use of such Intermediate or Raw Material as a component for further
manufacturing of Celera Products for use in the Field.


 


2.6.        Raw Materials. Celera will have the right to use Raw
Materials purchased from AB, to make, or have made by a Third Party
Manufacturer, Oligonucleotide Conjugates and to use such Oligonucleotide
Conjugates to make, have made, use, sell, offer for sale and/or import Celera
Products that incorporate such Oligonucleotide Conjugates; provided that such
Third Party Manufacturer is not infringing (i) the 5’ Nuclease IPR of
Roche, a partial list of which is as follows: 5,538,848, 5,723,591, 5,876,930,
6,030,787, 6,258,569, 5,804,375, 5,210,015 and 5,487,972; or (ii) AB’s dye
patents, a partial list of which is as follows: 6,649,598, 6,096,723,
6,303,775, 6,020,481, 6,008,379, 6,221,604. Celera will notify AB when it
selects such Third Party Manufacturer and AB will have 30 days to notify Celera
whether or not there is a reasonable and good faith basis to believe that the
Third Party Manufacturer is infringing the AB dye or 5’ Nuclease technology. AB
agrees that it will not commence an infringement action against such Third
Party Manufacturer by reason of its activities conducted for Celera pursuant to
this Section 2.6. Except for permitted transfers to Third Party
Manufacturers solely for the purpose of making Oligonucleotide Conjugates for
Celera, any sale or transfer of Raw Materials to a Third Party is specifically
prohibited. All agreements pursuant to which Raw Materials are transferred to a
Third Party Manufacturer will contain provisions providing that: (i) all
Raw Materials transferred will be deemed confidential information of AB; (ii) the
Third Party Manufacturer will not reverse-engineer any Raw Materials for so
long as they remain confidential information of AB; (iii) the Third Party
Manufacturer will not sell, re-sell, donate or otherwise transfer Raw Materials
to any Third Party; (iv) Celera will have the right, upon reasonable
notice and at its expense, to audit all use of the Raw Materials by the Third
Party Manufacturer to determine compliance with these provisions; and (v) all
Raw Materials will be and remain property of Celera, be subject to removal at
any time upon demand by Celera, be at all times clearly identified by the Third
Party Manufacturer as the property of Celera and be kept


 


[***] indicates material that
has been omitted pursuant to a request for confidential treatment. The omitted
material has been filed separately with the Securities and Exchange Commission.


 


6

















 


 


free of liens
and/or encumbrances of any kind. Scandinavian Gene Synthesis, Celera’s current
Third Party Manufacturer using Raw Materials, is approved by AB as a Third
Party Manufacturer.


 


2.7.        Custom Products. Celera may request AB to create customized
products. AB may accept or reject such a request at its discretion. In the
event AB agrees to create a customized product for Celera, the Parties will
amend this Agreement, or otherwise agree in writing, to include appropriate
special terms and conditions and thereafter such customized product will be
added as a New Product.


 


2.8           Grant of Rights.
(a) AB hereby grants to Celera, under AB’s IPR and, without AB having to
pay any additional consideration, under AB’s existing rights in any Third Party
IPR as of the Effective Date, all rights necessary (i) to make, have made,
use, sell, offer for sale and/or import Celera Products that incorporate
Products, and (ii) to convey to end-users all rights necessary to use
Celera Products that incorporate Products in the Field.


 


(b) Celera
will be responsible for securing access, at Celera’s cost and without any
contribution from AB, to any additional Third Party IPR Celera needs.


 


(c) AB
represents and warrants, to its Knowledge, that AB’s grant of the rights set
forth in Section 2.8(a) are free and clear of any additional
obligations of Celera to AB or a Third Party as to the Products on Exhibits A
and B and that, subject to the provisions of the next sentence, AB has the
necessary rights to sell such Products for use in Celera Products in the Field.
AB makes no representation and warranty with respect to Third Party IPR (i) where
AB’s patent attorneys and patent agents have a good faith, well reasoned legal
basis to believe that the claims of any Third Party IPR are invalid,
unenforceable or not infringed, or (ii) as to the matters set forth on
Schedule 2.8, or (iii) where any Named Representative of Celera has
Knowledge that AB does not have the rights set forth in Section 2.8(a) as
of the Effective Date free and clear of any additional obligations to a Third
Party. For the avoidance of doubt, AB would not be required to convey or obtain
any Third Party IPR for the Field where it does not have such rights to convey
as of the Effective Date, including in those instances where AB has prior to
the Effective Date procured a license to any Third Party IPR for fields other
than the Field, provided that AB’s representation and warranty in this Section 2.8(c) is
true.


 


(d) Notwithstanding
Section 2.8(b), in the event that AB breaches the foregoing representation
and warranty, AB’s sole obligation and Celera’s sole remedy (except for AB’s
indemnity obligations pursuant to Section 15.1) with respect to such
breach will be, at AB’s option, (a) to reimburse Celera for the
consideration paid by Celera to obtain the rights that are the subject of AB’s
breach of such representation and warranty, (b) to use commercially
reasonable efforts at AB’s cost to obtain such rights for Celera as soon as
reasonably feasible, or (c) if AB concludes that obtaining such rights for
Celera is not possible or commercially feasible, paying Celera such damages to
which Celera may be entitled under law for breach of such representation and
warranty, provided that in no event shall such amount exceed lost profits of
Celera as reasonably estimated by Celera for Celera’s inability to sell the
subject Celera Product during the [***] period commencing on the date Celera
ceased exercising the rights that are the subject of such breach.


 


[***] indicates material that
has been omitted pursuant to a request for confidential treatment. The omitted
material has been filed separately with the Securities and Exchange Commission.


 


7

















 


 


3                                         Term


 


3.1.        Initial Term. The term of this Agreement will commence on
the Effective Date and will, unless sooner terminated as provided herein, be in
full force and effect for seven years thereafter (the “Initial
Term”).


 


3.2.        Renewal. Following the Initial Term, this Agreement may be
renewed for consecutive one year terms by mutual agreement of the Parties
reached not later than 90 days prior to the expiration of the then-current
term. If after the Initial Term (or any renewal term) AB elects to terminate
this Agreement, Celera may thereafter reasonably demonstrate to AB that rights
to certain patents or patent applications owned or controlled by AB as to any
Product previously supplied to Celera are required for Celera to continue to
make, use or sell Celera Products. In such event, AB and Celera will discuss
and negotiate in good faith Celera’s access to such AB patents and patent
applications. For the avoidance of doubt, the preceding sentence is not a
binding commitment by either Party to conclude an agreement.


 


4                                         Termination


 


4.1                                 Default. Either Party may terminate this Agreement in the event
the other Party breaches any material obligation hereunder, other than for
non-payment of undisputed amounts past due, and, if such breach is capable of
being cured, such breach remains uncured for 90 days after receipt by the
defaulting Party of written notice of such default; provided,
however, that if such breach is amenable of cure but not within 90 days, and if the breaching
Party begins diligent efforts to
cure such breach promptly after
receipt of written notice thereof, then the breaching Party will have an
additional 90 days within which to cure
such breach provided that the breaching Party continues to use diligent efforts to cure such breach as soon as reasonably
possible. Notwithstanding the foregoing, where the breach is non-payment of
amounts due when payable, the cure period will be 30 days after receipt of
written notice of breach.


 


4.2                                 Acts of Insolvency. Either Party may terminate this
Agreement by written notice if the other Party becomes insolvent, makes a
general assignment for the benefit of creditors, suffers or permits the
appointment of a receiver for its business or assets, or has wound up or
liquidated, voluntarily or otherwise.


 


4.3                                 Challenge to AB Patents. AB may terminate sales of a Product
pursuant to this Agreement in the event Celera initiates any proceeding for the
purpose of challenging AB’s IPR in that Product. Celera will not be deemed to
have initiated such a proceeding if Celera challenges AB’s patent rights in a
Product as a defense or compulsory counterclaim in a proceeding initiated
against Celera by AB or as in a declaratory judgment action brought by Celera
against AB.


 


4.4                                 Force Majeure Event. If a Force Majeure Event (as defined in
Section 22.6) causing AB to fail to supply a Product continues for 60
consecutive days beyond the delivery date for such Product, Celera will have
the right to terminate its obligations under the Agreement with respect to that
Product on 30 days written notice to AB, or provide AB with written notice of
its intent to invoke the provisions of Section 2.4.


 


[***] indicates material that
has been omitted pursuant to a request for confidential treatment. The omitted
material has been filed separately with the Securities and Exchange Commission.


 


8

















 


 


4.5                                 Effect of Termination. Obligations incurred, including
purchase orders accepted, prior to the effective date of termination will not
be affected by termination, provided, however, that if the basis for
termination is non-payment of invoices or acts of insolvency, the terminating
Party may cancel all outstanding purchase orders without penalty or restocking
fee.


 


4.6                                 Effect of Third Party Acquisition. In the event Celera is acquired by a Third
Party during the term or any extended term of this Agreement, then the
purchasing volume of Products and Instruments on Exhibits A and B will be
limited to increases determined by the reasonable requirements to support
Celera’s or a
successor’s on-going business. Such reasonable requirements will be based on the
size of Celera’s business as of the Effective Date of the Separation Agreement,
as increased to take into account subsequent increases in Celera’s or a Third
Party acquirer’s sales volume because of: (i) increased sales of existing
products; (ii) sales of newly introduced products in the Field; and (iii) the
acquisition of other companies or their assets.


 


4.7                                 Return of Confidential Information. Upon cancellation,
termination or expiration of this Agreement, upon written request of a Party,
each Party agrees to immediately deliver to the other Party or destroy all
documents, data, records, notebooks, and similar writings relating in any way
to any Confidential Information of the other Party, including copies then in
such Party’s possession, whether prepared by that Party or others. If any such
documents are destroyed, the Party destroying same will certify to such
destruction in writing. Neither Party will retain any such documents, data, or
other items originated by the other Party, except one copy may be retained for
legal archive purposes.


 


4.8                       Surviving Provisions. The rights and obligations of the
Parties set forth under Sections
                                                      
and any other provisions that are expressly stated to survive termination of
this Agreement will survive termination of this Agreement for any reason. All
other rights and obligations of the Parties will cease on termination of this
Agreement.


 


5                                         Price


 


5.1                                 Price. The price of each Product will be the price set forth
on Exhibit A. The price applicable to a Product may be adjusted pursuant
to the terms of Section 5.2.


 


5.2                                 Price
Changes. The prices set forth in Exhibit A are firm for
the first year following the Effective Date. After the first year of the
Initial Term, AB may increase the prices set forth in Exhibit A not more
frequently than once in any twelve (12) month period, provided that the maximum
percentage change for a Product over the previous price for such Product shall
be limited to a percentage which is calculated as provided below. Any such
change in the Product prices will be effective for all Products ordered after July 1st
of the next July 1 to June 30 fiscal year (the “Fiscal Year”). Each annual change to
the Product prices will be determined using one of the following formulas
depending on type of Product using calculations to one decimal place.


 


5.2.1  Price
Change Formula for BDT Products Containing the [***] Enzyme. The Parties agree to calculate price changes for BDT
Products containing the [***] enzyme using a


 


[***] indicates material that
has been omitted pursuant to a request for confidential treatment. The omitted
material has been filed separately with the Securities and Exchange Commission.


 


9

















 


 


formula
based on the Employment Cost Index for Total Compensation for the Pacific
Region (“ECI”) as it appears on http://www.bls.gov/ro9/eciwest.htm, and the
annual change, if any, in the AB purchase price of the enzyme [***]. The price
of Products may change by an amount determined by AB in its sole discretion,
provided that any increase for such Product from one Fiscal Year to the next
will not exceed the price for that Product in effect during the preceding
Fiscal Year increased by a percent equal to the weighted average percent
increase of two pricing components over the same period.  By the first 15th of May following
the Effective Date and by each May 15th thereafter during the term
of the Agreement, the Parties will calculate a pricing adjustment determined by
the combined percentage of: i) a weighting of 20.0% times the annual percentage
of change from the previous 12 month average from April 1st to March 31st
in the ECI and ii) a weighting of 80.0% times the annual change in the AB
purchase price of the Roche Enzyme [***], with an example as follows.


 


20% (12
month avg percent change of ECI) plus 80% (annual price change in purchase price of [***]
enzyme) = % of maximum price increase/yr


 


Example - Price Change Formula for BDT
Products containing the enzyme [***]


 


A.     Establish: Appropriate Index and Weighted Averages


 


	
   

  	
  20%

  	
  BLS - Employment Cost Index for
  the Pacific Region

  
	
   

  	
  80%

  	
  AB Purchase Price of [***]

  



 


B.     Establish: Timing, Index Base values, and Annual Index Change


 


         1.             Establish Timing Convention


 




	
   

  	
  Period Start

  	
   

  	
  4/1/2007

  	
   

  	
  4/1/2008

  	
   

  	
  4/1/2009

  	
   

  
	
   

  	
  Period End

  	
   

  	
  3/31/2008

  	
   

  	
  3/312009

  	
   

  	
  3/31/2010

  	
   

  
	
   

  	
  Known As:

  	
   

  	
  Base
  Yr.

  	
   

  	
  Year
  1

  	
   

  	
  Year
  2

  	
   

  






 


         2.             Establish Monthly
Average of the 12 Months in the Period


 




	
   

  	
   

  	
   

  	
  Base Yr.

  	
   

  	
  Year 1

  	
   

  	
  Year 2

  	
   

  
	
   

  	
  ECI-Pacific

  	
   

  	
  160

  	
   

  	
  170

  	
   

  	
  190

  	
   

  
	
   

  	
  [***]

  	
   

  	
  $

  	
  2,000

  	
   

  	
  $

  	
  2,200

  	
   

  	
  $

  	
  2,300

  	
   

  
												






 


         3.             Establish Percentage
Change from the Prior Period


 




	
   

  	
   

  	
   

  	
  Base Yr.

  	
   

  	
  Year 1

  	
   

  	
  Year 2

  	
   

  
	
   

  	
  ECI-Pacific

  	
   

  	
   

  	
   

  	
  6.3

  	
  %

  	
  11.8

  	
  %

  
	
   

  	
  [***]

  	
   

  	
   

  	
   

  	
  10.0

  	
  %

  	
  4.5

  	
  %

  






 


C.      Calculate for Year 1 -
Annual Blended Index Pricing Change


 


         1.             Establish Percentage Change from the Prior
Period


 




	
   

  	
   

  	
   

  	
  Year 1

  % Blend

  	
   

  	
  Year 1% of

  Index Change

  	
   

  	
  Year 1 Weighted%

  	
   

  
	
   

  	
  ECI-Pacific

  	
   

  	
  20.0

  	
  %

  	
  6.3

  	
  %

  	
  1.3

  	
  %

  
	
   

  	
  [***]

  	
   

  	
  80.0

  	
  %

  	
  10.0

  	
  %

  	
  8.0

  	
  %

  






 


	
   

  	
  2.

  	
  Pricing on Products can
  change up to:

  	
  9.3

  	
  %

  



 


[***] indicates material that
has been omitted pursuant to a request for confidential treatment. The omitted
material has been filed separately with the Securities and Exchange Commission.


 


10

















 


 


5.2.2 Price
Change Formula for BDT Products containing enzymes other than [***]. The
following formula will govern price changes for BDT Products containing enzymes
other than [***] on Exhibit A. The Parties agree to use weighted average
percentage method of price adjustment such that the price of Products will change
by an amount determined by AB in its sole discretion, provided that any
increase for a Product from one Fiscal Year to the next will not exceed the
price for the Product in effect during the preceding Fiscal Year increased by a
percent equal to the weighted average percent increase of two published indexes
over the same period. The Parties agree to use a composite index based on the
weighted average of the previous 12-month average, from April 1st to March 31st,
of both the ECI and the Producer Price Index for In vitro Manufacturing
Substances (“PPI”). By the first 15th of May following the
Effective Date and by each May 15th thereafter during the Term
of the Agreement, the Parties will calculate a straight line average of the
previous 12 months (April through March of each annual period) for
each of the PPI (as defined above) as it appears on the Bureau of Labor
Statistics website  http://www.bls.gov/ppi/home.htm under In
Vitro Diagnostic Substances Manufacturing PPI code 06371402 and the ECI
as it appears in the Bureau of Labor Statistics website
http://www.bls.gov/ro9/eciwest.htm, or if discontinued such equivalent index as
is mutually agreed to by the Parties. AB will notify Celera of any increase in
price of a Product at least thirty (30) days prior to the date on which the
increase will take effect. The pricing adjustment will be determined by the
combined percentage of: i) a weighting of 70.0% of the average percent change
of the previous 12 months from April 1st to March 31st in the ECI
plus ii) a weighting of 30.0% of the average percent change of the previous 12
months from April 1st to March 31st in the PPI, with an example as
follows.


 


70% (12 month avg percent change of ECI) plus 30%
(12 month avg change of PPI) = % of maximum price increase/yr


 


Example - Price Change Formula for BDT Products
containing enzymes other than [***]


 


A.    Establish:
Appropriate Index and Weighted Averages


 




	
   

  	
  70%

  	
  BLS - Employment Cost Index for the Pacific Region

  
	
   

  	
  30%

  	
  BLS - PPI for In Vitro Manufactured Substances

  






 


B.     Establish:
Timing, Index Base values, and Annual Index Change


 


         1.             Establish Timing Convention


 




	
   

  	
  Period Start

  	
   

  	
  4/1/2007

  	
   

  	
  4/1/2008

  	
   

  	
  4/1/2009

  	
   

  
	
   

  	
  Period End

  	
   

  	
  3/31/2008

  	
   

  	
  3/31/2009

  	
   

  	
  3/31/2010

  	
   

  
	
   

  	
  Known As:

  	
   

  	
  Base Yr.

  	
   

  	
  Year 1

  	
   

  	
  Year 2

  	
   

  






 


[***] indicates material that
has been omitted pursuant to a request for confidential treatment. The omitted
material has been filed separately with the Securities and Exchange Commission.


 


11

















 


 


         2.              Establish Monthly
Average of the 12 Months in the Period


 




	
   

  	
   

  	
   

  	
  Base Yr.

  	
   

  	
  Year 1

  	
   

  	
  Year 2

  	
   

  
	
   

  	
  ECI-Pacific

  	
   

  	
  160

  	
   

  	
  170

  	
   

  	
  190

  	
   

  
	
   

  	
  PPI Invitro Mfg.

  	
   

  	
  180

  	
   

  	
  175

  	
   

  	
  185

  	
   

  






 


         3.              Establish Percentage
Change from the Prior Period


 




	
   

  	
   

  	
   

  	
  Base Yr.

  	
   

  	
  Year 1

  	
   

  	
  Year 2

  	
   

  
	
   

  	
  ECI-Pacific

  	
   

  	
   

  	
   

  	
  6.3

  	
  %

  	
  11.8

  	
  %

  
	
   

  	
  PPI Invitro Mfg.

  	
   

  	
   

  	
   

  	
  -2.8

  	
  %

  	
  5.7

  	
  %

  






 


C.     Calculate
Annual Index-Based Pricing Change


 


         1.              Establish Percentage
Change from the Prior Period


 




	
   

  	
   

  	
   

  	
   

  	
  Year 1 

  % Blend

  	
   

  	
  Year 1 % of

  Index Change

  	
   

  	
  Year 1 Weighted %

  	
   

  
	
   

  	
   

  	
  ECI-Pacific

  	
   

  	
  70.0

  	
  %

  	
  6.3

  	
  %

  	
  4.4

  	
  %

  
	
   

  	
   

  	
  PPI Invitro Mfg.

  	
   

  	
  30.0

  	
  %

  	
  -2.8

  	
  %

  	
  -0.8

  	
  %

  






 




	
   

  	
  2.

  	
  Pricing on Products can
  change up to by:

  	
  3.5

  	
  %

  






 


5.2.3 Price
Change Formula for Other Products. The following formula will govern price
changes for all Products on Exhibit A except those Products in Section 5.2.1
and 5.2.2 above. The Parties agree to use weighted average percentage method of
price adjustment such that the price of Products will change by an amount
determined by AB in its sole discretion, provided that any increase for a
Product from one Fiscal Year to the next will not exceed the price for the
Product in effect during the preceding Fiscal Year increased by a percent equal
to the weighted average percent increase of two published indexes over the same
period. The Parties agree to use a composite index based on the weighted
average of the previous 12-month average, from April 1st to March 31st,
of both the ECI and the PPI. By the first 15th of May following
the Effective Date and each May 15th thereafter during the term
of the Agreement, the Parties will calculate a straight line average of the
previous 12 months (April through March of each annual period) for
each of the PPI as it appears on the Bureau of Labor Statistics website www.bls.gov
under In Vitro Diagnostic Substances Manufacturing, PPI code 06371402 and the ECI
as it appears in the Bureau of Labor Statistics website
http://www.bls.gov/ro9/eciwest.htm, or if discontinued such equivalent index as
is mutually agreed to by the Parties. AB will notify Celera of any increase in
price of a Product at least thirty (30) days prior to the date on which the
increase will take effect. The pricing adjustment will be determined by the
combined percentage of: i) a weighting of 40.0% of the average percent change
of the previous 12 months from April 1st to March 31st in the ECI
plus ii) a weighting of 60.0% of the average percent change of the previous 12
months from April 1st to March 31st in the PPI, with an example as
follows.


 


40% (12
month avg change of
ECI) plus 60% (12 month avg change of PPI) = % of maximum price
increase/yr


 


[***] indicates material that
has been omitted pursuant to a request for confidential treatment. The omitted
material has been filed separately with the Securities and Exchange Commission.


 


12














 


 


Example - Price Change Formula for all Other
AB Products


 


A.          Establish: Appropriate Index and Weighted
Averages


 


40%                         BLS - Employment Cost Index for the Pacific Region


60%                         BLS - PPI for In Vitro Manufactured Substances


 


B.            Establish:
Timing, Index Base values, and Annual Index Change


 


1.              Establish
Timing Convention


 


	
  Period Start

  	
   

  	
  4/1/2007

  	
   

  	
  4/1/2008

  	
   

  	
  4/1/2009

  
	
  Period End

  	
   

  	
  3/31/2008

  	
   

  	
  3/31/2009

  	
   

  	
  3/31/2010

  
	
  Known As:

  	
   

  	
  Base Yr.

  	
   

  	
  Year 1

  	
   

  	
  Year 2

  



 


2.              Establish
Monthly Average of the 12 Months in the Period


 


	
   

  	
   

  	
  Base Yr.

  	
   

  	
  Year 1

  	
   

  	
  Year 2

  	
   

  
	
  ECI-Pacific

  	
   

  	
  160

  	
   

  	
  170

  	
   

  	
  190

  	
   

  
	
  PPI Invitro Mfg.

  	
   

  	
  180

  	
   

  	
  175

  	
   

  	
  185

  	
   

  



 


3.              Establish
Percentage Change from the Prior Period


 


	
   

  	
   

  	
  Base Yr.

  	
   

  	
  Year 1

  	
   

  	
  Year 2

  	
   

  
	
  ECI-Pacific

  	
   

  	
   

  	
   

  	
  6.3

  	
  %

  	
  11.8

  	
  %

  
	
  PPI Invitro Mfg.

  	
   

  	
   

  	
   

  	
  -2.8

  	
  %

  	
  5.7

  	
  %

  



 


C.            Calculate
Annual Index-Based Pricing Change


 


1.              Establish
Percentage Change from the Prior Period


 


	
   

  	
   

  	
  Year 1

  % Blend

  	
   

  	
  Year 1%

  of Index Change

  	
   

  	
  Year 1 Weighted

  %

  	
   

  
	
  ECI-Pacific

  	
   

  	
  40.0

  	
  %

  	
  6.3

  	
  %

  	
  2.5

  	
  %

  
	
  PPI Invitro Mfg.

  	
   

  	
  60.0

  	
  %

  	
  -2.8

  	
  %

  	
  -1.7

  	
  %

  



 


	
  2.    Pricing on
  Products may change up to:

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  0.8

  	
  %

  



 


5.3                                Changed Costs. The Parties agree to negotiate in good faith
a reasonable adjustment to the price of a Product independent of adjustments
pursuant to Section 5.2 in the event of an increase in AB’s cost of
manufacture thereof purchased from Third Party suppliers, provided such
adjustments will occur, if ever, only once  in any 12
month period or at any time provided such costs increase by more than 10%, and
provided further that no price adjustment will be permitted to compensate AB
for royalties paid to obtain Third Party IPR, except to the extent set forth in
Section 2.8.


 


5.4                                Tax, Freight, and Insurance. The prices set forth in Exhibits A
and B are exclusive of all sales, excise or stamp taxes or similar charges,
assessments, fees or duties levied or assessed 


 


[***] indicates material that has been
omitted pursuant to a request for confidential treatment. The omitted material
has been filed separately with the Securities and Exchange Commission.


 


13

















 


 


on or for the sale or transportation of
Products and all transportation, freight, shipping, handling and insurance
charges, all of which will be separately invoiced to Celera.


 


5.5                                Audits. Upon the written request of Celera and not more than
once in each calendar year, AB will permit an independent certified public
accounting firm selected by Celera and reasonably acceptable to AB, at Celera’s
expense, to have access during normal business hours to such of the records of
AB as may be reasonably necessary to verify the accuracy of the New Product
Pricing, Pass-Through Royalties, PPI and ECI adjustments and changed cost
adjustments hereunder for any calendar year ending not more than 36 months
prior to the date of such request, subject to AB’s reasonable health and
safety, security and confidentiality requirements. The accounting firm will
disclose to Celera only whether the foregoing items are correct or incorrect
and the amount of any discrepancy. No other information will be provided to
Celera. If such accounting firm correctly identifies a discrepancy made during
such period, the appropriate Party will pay the other Party the amount of the
discrepancy within 30 days of the date Celera delivers to AB such accounting
firm’s written report so correctly concluding, or as otherwise agreed upon by
the Parties. The fees charged by such accounting firm will be paid by Celera; provided, however, that if AB is found to have erred in AB’s
favor by the greater of (a) $1,000,000 or (b) more than 5% for the
audited period, AB will reimburse Celera for the full cost of the performance
of such audit.


 


6                                        Orders


 


6.1                                Purchase Orders. To purchase Products hereunder, Celera and
its Affiliates (through any of their respective divisions or business units) may
issue purchase orders (“Purchase Orders”), which (a) will
specify the Purchase Order number, type and quantity of Product ordered, places
of delivery, and delivery dates, and (b) may also contain instructions as
to carrier and method of shipment, packaging and labeling, and other relevant
aspects regarding the supply of Products. If Celera fails to specify a carrier
and method of shipment, AB will select a suitable carrier and method of
shipment on a commercially reasonable basis. Celera will place each Purchase
Order with AB at least 10 business days in advance of the delivery date unless
other lead times are specified in Exhibit A with respect to certain
Products. AB will promptly accept and confirm all Purchase Orders issued in
accordance with this Agreement in writing within five business days from the
date of the Purchase Order. In the absence of an acceptance within such period,
the applicable Purchase Order will be deemed accepted by AB.


 


6.2                                Shipment. AB will ship Products subject to a Purchase Order
in accordance with the lead times specified in Exhibit A. Products will be
delivered in single shipments, unless otherwise specified by Celera on a
Purchase Order. In the event that AB
cannot deliver Products in a single shipment or a delay will occur to provide
such single shipment, AB will notify Celera and obtain Celera’s preference as
to how Products are to be shipped.


 


7                                        Forecasts


 


7.1                                Twelve Month Forecast. Celera will provide AB with a rolling
twelve month non-binding forecast of its orders for Products listed on Exhibit A.
The initial forecast will be delivered to AB within 30 days of the Effective
Date and updated quarterly thereafter. If a Product is designated on Exhibit A
as “OTS” (“off the shelf”), no forecast is
required. If a 


 


[***] indicates material that has been
omitted pursuant to a request for confidential treatment. The omitted material
has been filed separately with the Securities and Exchange Commission.


 


14

















 


 


Product is designated on Exhibit A as “MTO” (“made to order”), Celera will place orders for MTO
Products in concert with the lead times for such Products as set forth in Exhibit A.


 


7.2                                Changes in Purchase Orders. Celera may increase the
quantity, or request an earlier delivery date, of a Product ordered over the
quantity and delivery date specified in its firm purchase order for such
Product and AB will use commercially reasonable efforts to fill such orders
provided that the timing of the increased order falls within the agreed upon
lead time for such Product and taking into consideration AB’s obligations to
its other customers with respect to such Product. In no event is AB obligated,
nor will it be a breach of this Agreement if AB is unable, to fill an order
which is more than 125% in excess of the quantity specified in its firm
purchase order or to deliver such order earlier than originally agreed to.


 


8                                        Invoicing
and Payment


 


8.1                                Invoicing. AB will invoice Celera for Products shipped FOB
AB’s dock pursuant to Section 9 at the price per Product unit set forth on
Exhibit A. Invoices will include the applicable Purchase Order number,
quantity and part number of the Products shipped and prices therefor.


 


8.2                                Payment. Celera will pay AB for each Product shipped to
Celera no later than 30 days after receipt of an invoice therefore. AB will not
invoice Celera for a Product until a date that is on or after the date of
shipment of the Product to Celera. Invoicing and payment will be made in United
States dollars.


 


8.3                                Late Payments. If payment is not received by the due date,
AB may assess and Celera agrees to pay a late payment charge at the rate of 1%
per month (12% per year) or the maximum legal rate, whichever is less, of the
amount due from the due date to the date of payment.


 


8.4                                Collection. If AB retains a collection agency or attorney to
collect unpaid amounts, AB may invoice Celera for, and Celera will pay, all
reasonable costs of collection, including without limitation reasonable
attorneys fees.


 


9                                        Shipping,
Delivery and Packaging


 


9.1                                Shipping and Delivery. AB will ship Product so that it is
delivered to Celera on the delivery date, and Products will not be delivered
more than four calendar days prior to the delivery date without Celera’s prior
written consent. AB will notify Celera at the time of shipment as to the
quantity of Product shipped and the specific shipping information. Shipping
quantities may not vary from those established by the Purchase Order unless
otherwise mutually agreed upon in writing by the Parties. In the event any
shipment is delayed, Celera may direct AB to ship such Product by expedited
transportation designated by Celera and AB will bear the expense of any
difference in cost due to such expedited transportation. AB will promptly
notify Celera of its inability or expected inability to meet a delivery date.
AB will ship the Product to the delivery addresses set forth in the applicable
Purchase Order. Celera may, from time to time, instruct AB to deliver all or a
portion of Product ordered pursuant to a Purchase Order to non-Celera
locations. AB will at all times properly handle and store Products in
accordance with AB’s specifications and customary procedures. AB will solely
bear all risk of loss or damage and 


 


[***] indicates material that has been omitted
pursuant to a request for confidential treatment. The omitted material has been
filed separately with the Securities and Exchange Commission.


 


15

















 


 


all costs and expenses incurred by Celera for
storage or return with respect to quantities of Product shipped by AB in excess
of the quantities set forth in the applicable Purchase Order.


 


9.2                                Risk of Loss. Title and risk of loss with respect to all
Products will pass from AB to Celera upon transfer of possession of the Product
to a common or other Third Party carrier at AB’s facility.


 


9.3                                Packaging. Products will be packaged and prepared for
shipment (a) in a manner which (i) follows good commercial practice
and complies with all laws and regulations, including, without limitation, the
hazardous materials regulations set forth in 49 C.F.R. Sections 100 et seq.
(and any subsequent or successor versions thereof) and any other applicable
hazardous materials regulations, and (ii) is acceptable to, and complies
with any specific requirements of, the designated carrier and/or Celera agreed
to by AB in writing, , and (b) in accordance with any reasonable specific
packaging and labeling requirements set forth in the Purchase Order or the
Specifications. Each shipment will be accompanied by a packing slip which will
include Celera’s part numbers, Purchase Order number, AB’s part number, and the
quantity of Products contained in such shipment. AB will be responsible for all
losses or damages caused by or due to any improper packaging.


 


10                                 Quality


 


10.1                          Quality Management System. AB will maintain a Quality
Management System designed to comply, at a minimum, with ISO 9001:2000 at
facilities at which Products are manufactured.


 


10.2                          Certificate of Analysis. AB will deliver certificates of
analysis with Products when delivered to Celera for those Products with respect
to which it is AB’s customary practice with its commercial customers to do so,
and for those Products with respect to which AB and Celera have developed a
certificate of analysis pursuant to the last sentence of this Section 10.2.
If a certificate of analysis has not previously been provided to Celera or is
not provided as a routine matter for a particular Product, or if Celera wishes
and AB agrees to a certificate of analysis for a Product in a format different
than the one furnished by AB to its commercial customers, the Parties will in
good faith seek to agree on the form of a certificate of analysis, and AB will
provide a certificate of analysis in the agreed upon format if the Parties do
agree, and the reasonable development expense and/or increase in cost required
to generate such certificate of analysis will be paid by Celera or reimbursed
to AB by Celera, unless otherwise agreed to by the Parties.


 


10.3                          Product Changes. AB agrees to notify Celera of a change in
composition to or method of manufacture of a Product listed on Exhibit A
or Exhibit B to the extent that AB determines that a change affects the
form, fit or function of the Product and results in a change to the final
Product Specifications (a “Material Product Change”).
Such notification may be in the form of a letter from AB distributed generally
to its customers. Notwithstanding the foregoing, if a Product is manufactured
or supplied by a Third Party, AB’s ability and agreement to provide notice of
change as set forth herein above is subject to AB receiving written change
information from the manufacturer or supplier that notifies AB of a change in
the Product’s Specifications. The parties may designate on Exhibit A
Products for which no Material 


 


[***] indicates material that has been
omitted pursuant to a request for confidential treatment. The omitted material
has been filed separately with the Securities and Exchange Commission.


 


16

















 


 


Product Change can be knowingly made without
AB and Celera first discussing the effect of any such proposed change. If any
Product is so designated, AB will not knowingly make a Material Product Change
to the Product without first notifying Celera in writing and discussing
possible effects of such change.  Celera’s sole
and exclusive remedy, and AB’s sole and exclusive obligation and liability, for
failure to notify Celera of any Material Product Change as required by this Agreement
will be for AB to use its commercially reasonable efforts to fulfill as soon as
reasonably feasible a single order for such Product, with the Specifications in
effect prior to the Material Product Change, that is placed by Celera with AB
within 60 days of Celera’s receiving notification of the Material Product
Change. Such order will be in the amount of Product that Celera estimates it
will need for the following two years in accordance with the provisions of Section 2.3,
provided that AB will not be required to fulfill such an order placed by Celera
if, in AB’s reasonable determination, the Material Product Change would result
in health and safety concerns, and in which event AB’s sole and exclusive
obligation and liability will have been satisfied.


 


10.4                          Specifications. AB will manufacture and supply all Products
to AB’s most recent Specifications for the Product (that is, AB’s most recent
public written specifications or, with respect to Products for which AB and
Celera have agreed upon specifications, such agreed upon Specifications).
Except as may be otherwise set forth in Section 10.3, nothing in this
Agreement will be deemed restrict or limit AB from making changes to any
product specifications, including without limitation the Specifications of
Products listed on Exhibits A and B, provided that, subject to Section 10.3,
AB will give Celera prior written notice of any changes to Specifications of
Products listed on Exhibits A and B.


 


10.5                          Additional Quality Terms. Celera may request additional terms
regarding the quality of a Product. In such an event the Parties will conduct
good faith discussions regarding such additional quality terms and to the
extent that such a request is within the reasonable capabilities of AB, AB may
include at AB’s discretion such additional quality terms for the specified
Product, provided that doing so may result in the creation of a New Product
with new pricing at AB’s discretion.


 


11                                 Manufacturing
Processes


 


11.1                          Document Retention. AB will maintain all material records
documenting the manufacture, testing and shipment of the Products supplied to
Celera (“Celera Product Documents”) for a
period of five years following the shipment of the Celera Products to Celera or
its designee; provided, however, that AB will
notify Celera prior to destruction of any Celera Product Documents and send
them to Celera, at Celera’s cost, if so requested. AB will allow Celera to
review such Celera Product Documents during any site inspection conducted under
the terms of this Agreement and at other reasonable times at the request of
Celera, in all cases subject to AB’s reasonable health and safety, security,
and confidentiality requirements. Celera Product Documents will be confidential
information of AB, provided however that Celera may disclose such Celera
Product Documents to a Distributor as necessary, and to applicable regulatory
authorities if required to do so under law, subject to satisfaction of AB’s
reasonable confidentiality requirements, which may include, if AB wishes,
signing of a confidentiality agreement in form satisfactory to AB and marking
all documents to protect same under Freedom of Information Act and other
disclosure laws or regulations.


 


[***] indicates material that has been
omitted pursuant to a request for confidential treatment. The omitted material
has been filed separately with the Securities and Exchange Commission.


 


17

















 


 


11.2                          Site Inspections. Upon reasonable prior notice, AB will,
from time to time during the term or any extended term of this Agreement, allow
representatives of Celera to tour and inspect AB facilities utilized by AB in
the manufacture or refurbishing of Celera Products, at reasonable times and
upon reasonable advance notice for the purposes of verifying compliance with
the terms of this Agreement. Any such inspections will not occur more than once
in any calendar year, and will be subject to AB’s reasonable health and safety,
security, and confidentiality requirements.


 


11.3                          Regulatory Inspections. AB will allow representatives of the
FDA or other applicable regulatory or governmental authorities to tour and
inspect all facilities utilized by AB in the manufacture, testing, packaging
and storing of Celera Products, provided that the foregoing will not be deemed
a waiver by AB of any rights or remedies it may have under law or restrict AB
from insisting on reasonable health and safety, security or confidentiality
requirements.


 


11.4                          Responsibility for Regulatory Matters.                               All regulatory matters regarding obtaining and
maintaining any necessary clearance or other permit, permission, consent or
approval, or promotion or labeling, or otherwise complying or assuring
compliance with applicable law for or relating to the importation, sale and use
of Celera Products, if any such requirements exist, from the FDA, or under the
European IVD Directive or any other body or agency, will remain under the
exclusive control of Celera and will be solely Celera’s responsibility. AB will
provide Celera access to documentation under AB’s control reasonably required
for Celera Product regulatory registration (subject to AB’s reasonable
confidentiality requirements), provided that any such registration will not
impose any duties or requirements on AB or require AB to take any action except
to permit regulatory inspections as and to the extent expressly set forth in Section 11.3
of this Agreement.


 


12                                 Defects
and Returns


 


12.1                          Rejected Products. Any claims for damaged, missing or
defective Product must be reported in writing by Celera within 15 days from the
date of Celera’s receipt of the Product, after which time the order will have
been deemed to be accepted. In addition, Celera must promptly return a rejected
Product to AB, C.O.D, unused and in a condition no worse than that delivered to
Celera and in the Product’s original containers and packing material,
accompanied by a valid return authorization number obtained from AB, which will
not be unreasonably withheld or delayed. AB may refuse any Product not timely
rejected or sought to be returned without a valid return authorization number.
For any valid claim timely made, AB, at its option, may repair the Product or
replace the Product with an identical or substantially similar Product.
Shipping charges will not be credited.


 


12.2                          Sole Remedy. THE PROVISIONS OF SECTION 12 SET FORTH
CELERA’S SOLE AND EXCLUSIVE REMEDIES FOR A DAMAGED OR MISSING PRODUCT, AND,
EXCEPT FOR EXPRESS WRITTEN WARRANTY RIGHTS, FOR A DEFECTIVE PRODUCT.


 


12.3                          Decontamination. AB may require that Celera sign and deliver
a properly completed certificate of decontamination prior to returning any
Product.


 


[***] indicates material that has been
omitted pursuant to a request for confidential treatment. The omitted material
has been filed separately with the Securities and Exchange Commission.


 


18

















 


 


13           General Warranty


 


13.1                          Express Warranties. Except as otherwise provided herein, AB
makes only those warranties with respect to Product expressly identified as “warranties”
and set forth in AB’s current operating manual or catalog, or in a specific
written warranty included with and covering a Product, if any.


 


13.2                          No Pass Through. Warranties are made only to the Celera as
the entity purchasing the Product directly from AB, are not transferable and do
not extend to the benefit of any other person or entity, unless otherwise
expressly stated in writing by AB.


 


13.3                          “AS IS”. EXCEPT AS OTHERWISE PROVIDED HEREIN, ANY PRODUCT
NOT COVERED BY AN EXPRESS WRITTEN WARRANTY IS SOLD AND PROVIDED “AS IS,”
WITHOUT WARRANTY OF ANY KIND, STATUTORY, EXPRESS OR IMPLIED.


 


13.4                          Descriptions, Models and Samples. Any description of Product
recited in AB’s quotation is for the sole purpose of identifying Product, and
any such description is not part of any contract between AB and Celera and does
not constitute a warranty that Product will conform to that description. Any
sample or model used in connection with AB’s quotation is for illustrative
purposes only, and is not part of any contract between AB and Celera and does
not constitute a warranty that Product will conform to the sample or model. No
affirmation of fact or promise made by AB, whether or not in AB’s quotation,
will constitute a warranty that Product will conform to the affirmation or promise.
Unless otherwise specified in writing in documentation shipped with Product or
otherwise agreed by AB in writing, AB does not provide service or support for
custom products or other products made to buyer’s specifications.


 


13.5                          Sole and Exclusive. EXCEPT AS OTHERWISE PROVIDED HEREIN, THE
WARRANTIES IDENTIFIED IN SECTION 13.1 ARE APPLERA’S SOLE AND EXCLUSIVE
WARRANTIES WITH RESPECT TO THE PRODUCTS AND ARE IN LIEU OF ALL OTHER
WARRANTIES, STATUTORY, EXPRESS OR IMPLIED, ALL OF WHICH OTHER WARRANTIES ARE
EXPRESSLY DISCLAIMED, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTY OF
MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, OR
REGARDING RESULTS OBTAINED THROUGH THE USE OF ANY PRODUCT (INCLUDING, WITHOUT
LIMITATION, ANY CLAIM OF INACCURATE, INVALID OR INCOMPLETE RESULTS), WHETHER
ARISING FROM A STATUTE OR OTHERWISE IN LAW OR FROM A COURSE OF PERFORMANCE,
DEALING OR USAGE OF TRADE.


 


14           Limitation of Liability


 


14.1                          Disclaimer of Consequential Damages. EXCEPT AS PROVIDED
HEREIN AND FOR BREACHES OF SECTION 18 (CONFIDENTIALITY) , IN NO EVENT WILL
EITHER PARTY BE LIABLE TO THE OTHER, WHETHER IN CONTRACT, TORT, WARRANTY, OR
UNDER ANY STATUTE (INCLUDING WITHOUT LIMITATION ANY TRADE PRACTICE, UNFAIR
COMPETITION OR OTHER STATUTE OF SIMILAR IMPORT) OR ON ANY OTHER BASIS, FOR
INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, MULTIPLE, OR PUNITIVE DAMAGES OF
THE OTHER 


 


[***] indicates material that has been
omitted pursuant to a request for confidential treatment. The omitted material
has been filed separately with the Securities and Exchange Commission.


 


19

















 


 


PARTY OR ITS AFFILIATES, WHETHER OR NOT
FORESEEABLE AND WHETHER OR NOT THE OTHER PARTY IS ADVISED OF THE POSSIBILITY OF
SUCH DAMAGES, INCLUDING, WITHOUT LIMITATION, DAMAGES ARISING FROM OR RELATED TO
THE USE OR PERFORMANCE OF PRODUCTS, LOSS OF USE, LOSS OF DATA, FAILURE OR
INTERRUPTION IN THE OPERATION OF ANY EQUIPMENT, DELAY IN REPAIR OR REPLACEMENT,
FAILURE OF ANY PRODUCT TO OPERATE OR PERFORM AS INTENDED, OR LOSS OF
GOODWILL. For the avoidance of doubt, the provisions of this Section 14.1
are not intended to be a waiver of any damages of a Third Party subject to a
Party’s indemnification obligations under Sections 15 and 16.


 


15           General Indemnification


 


15.1                          Indemnification by AB.


 


(a)                                 AB
will defend, indemnify and hold harmless Celera, its Affiliates and their
respective directors, officers, employees and agents (“Celera
Indemnitees”) (for purposes of this Section 15 the term “Indemnitee” may refer to either or both the AB Indemnitees
and the Celera Indemnitees, as the context may indicate) from and against:


 


(i) any
and all claims for losses, damages or expenses asserted by a Third Party
against Celera or any of its Affiliates to the extent caused by the material
breach of any representation, warranty or covenant made by AB in this
Agreement, the negligence (including gross negligence) or willful misconduct of
AB, or the manufacture by AB of a Defective Item, in all cases above to the
extent the claimed loss, damage or expense is for personal injury to or death
of a human (including without limitation employees of Celera) or damage or
destruction to tangible property, but excluding in all cases above Diagnostic
Losses except to the extent subject to AB’s indemnity set forth below in
subclause (ii) of this Section 15.1;


 


(ii) Diagnostic
Losses to the extent, and only to the extent, resulting from the gross
negligence or willful misconduct of AB; and


 


(iii) any
and all claims for losses, damages or expenses asserted by a Third Party
against Celera or any of its Affiliates to the extent caused by AB’s breach of
the representations, warranties and/or covenants made by AB in Section 2.8
(Grant of Rights) of this Agreement, subject to a cap of $[***].


 


(b)                                AB
will also indemnify and hold harmless Celera from and against Celera’s
reasonable attorneys’ fees and costs in defending any claims subject to AB’s
indemnity set forth above in Section 15.1(a) with respect to which AB
has not undertaken Celera’s defense, except to the extent otherwise set forth
in Section 15.3.


 


15.2                          Indemnification by Celera.


 


(a)                                 Except
with respect to claims expressly subject to AB’s indemnity of Celera set forth
in Section 15.1, Celera will defend, indemnify and hold harmless AB, its
Affiliates and their respective directors, officers, employees and agents (“AB Indemnitees”) from and against any and all claims for
losses, damages or expenses asserted by a Third Party against AB or any of its
Affiliates caused by:


 


[***] indicates material that has been
omitted pursuant to a request for confidential treatment. The omitted material
has been filed separately with the Securities and Exchange Commission.


 


20

















 


 


(i) the
material breach of any representation, warranty or covenant made by Celera in
this Agreement, the negligence (including gross negligence) or willful
misconduct of Celera;


 


(ii) the
possession, manufacture, sale, storage, use or transportation of Celera
Products or parts or components thereof by any person (including without
limitation by any governmental entity), including, without limiting the
generality of the foregoing, claims for personal injury to or death of any
person (including without limitation employees of AB or Celera) or damage or
destruction of tangible property, Diagnostic Losses, even if caused by or
alleged to have been caused by the negligence of AB but not to the extent
caused by the gross negligence or willful misconduct of AB, or the failure of
any Celera Product or any component thereof to be qualified, registered or
approved under any applicable law; and


 


(iii) any
and all claims for losses, damages or expenses asserted by a Third Party
against AB or any of its Affiliates to the extent caused by Celera’s breach of
the representations and warranties made by Celera in Section 2.8 (Grant of
Rights) of this Agreement, subject to a cap of $[***].


 


(b)                                Celera
will also indemnify and hold harmless AB from and against AB’s reasonable
attorneys’ fees and costs in defending any claims subject to Celera’s indemnity
set forth above in Section 15.2(a) with respect to which Celera has
not undertaken AB’s defense, except to the extent otherwise set forth in Section 15.3.


 


15.3                         Conditions of Indemnification, Procedures.


 


(a)                                 In any action for
which a Party seeks indemnity from the other Party under this Section 15,
the Party seeking indemnification will tender the defense to the other Party,
and if such other Party accepts such indemnity and agrees in writing that it
will defend, indemnify and hold harmless the Party seeking indemnification
pursuant to this Section 15, such other Party will have the sole right to
control and conduct the defense and/or settlement of such action, either in the
name of Celera or AB or both with counsel mutually satisfactory to the Parties.
In the event a Party disagrees as to whether it is obligated to indemnify the
other under Section 15.3 with respect to for one or more claims, it will
so promptly notify the other Party, and the Parties will promptly meet to
evaluate whether the evidence then available to the Parties reasonably supports
such claim. If the Parties cannot agree, the matter will be addressed and
finally determined in accordance with the dispute resolution provisions of the
Separation Agreement. Until a final determination is made, the Party seeking
indemnification hereunder may appear and defend in such action and, if the
indemnification provisions are determined to apply, the Party found to be
obligated to indemnify will reimburse the Party seeking indemnification for
such Party’s reasonable out of pocket legal fees and expenses for the defense
of such action.


 


(b)                                If
a Party or Indemnitee intends to claim indemnification under this Section 15.3,
it will promptly notify the other Party (the “Indemnitor”)
in writing of any claim, demand, action or other proceeding for which the
Indemnitee intends to claim such indemnification, and the Indemnitor may
participate in, and, to the extent the Indemnitor so desires, assume the
defense of, such claim, demand, action or proceeding with counsel mutually
satisfactory to the Parties; provided, however,
that an Indemnitee will have the right to retain its own counsel, with the fees
and expenses to be paid by the Indemnitor, if representation of such Indemnitee
by the 


 


[***] indicates material that has been
omitted pursuant to a request for confidential treatment. The omitted material
has been filed separately with the Securities and Exchange Commission.


 


21

















 


 


counsel retained by the Indemnitor would be
inappropriate due to actual or potential differing interests between the
Indemnitee and any other Party represented by such counsel in such proceeding.
The obligations of this Section 15.3 will not apply to amounts paid in
settlement of any claim, demand, action or other proceeding if such settlement
is effected without the consent of the Indemnitor, which consent will not be
unreasonably withheld or delayed. The failure to deliver written notice to the
Indemnitor within a reasonable time after the commencement of any such action,
if materially prejudicial to its ability to defend such action, will relieve
the Indemnitor of any obligation to the Indemnitee under this Section 15.3,
but otherwise the Indemnitor will not be relieved of its indemnity and defense
obligations on account of any failure or delay to deliver notice of a claim.
The Indemnitee will reasonably cooperate with the Indemnitor and its legal
representatives in the investigation of any claim, demand, action or other
proceeding covered by this Section 15.3. An Indemnitor will not agree to
the settlement of any claim without the consent of the other Party, which will
not be unreasonably withheld or delayed.


 


16           Intellectual Property
Indemnification


 


16.1                          Indemnity by AB. Subject to the restrictions set forth in
this Section 16 and provided Celera complies with its obligations in this Section 16,
AB agrees to defend Celera, and indemnify Celera from and against any
infringement damages finally awarded, in any legal action or proceeding brought
by a Third Party against Celera to the extent that such action is based on a
claim that the manufacture and sale of a Product by AB infringes any United
States or foreign patent, copyright, trademark or other Intellectual Property
Right of such Third Party if AB had actual knowledge of such intellectual
property right and infringement at the time of delivery of the Product to
Celera. Notwithstanding the foregoing, AB will have no liability or obligation
under this Section 16 with respect to any claim of infringement based
upon: (i) modifications to any Product made by Celera or a Third Party; or
(ii) manufacture, assembly, labeling or branding of Product by AB pursuant
to specifications or designs or requests for specific labeling or branding
furnished by Celera. Notwithstanding anything herein to the contrary, AB will
have no indemnification obligations with respect to Product originating from a
Third Party and provided under this Agreement. Celera’s sole right to indemnification
with respect to such Third Party Product will be pursuant to the original
manufacturer’s or licensor’s indemnification obligations, if any, to the extent
provided by the original manufacturer or licensor.


 


16.2                          Celera’s Obligations. Celera must notify AB in writing of
any claim for which it may seek defense and indemnity from AB hereunder
promptly after becoming aware of such claim, make no admission of liability
with respect to the claim, and cooperate with and provide reasonable assistance
to AB, at AB’s expense with respect to reasonable out of pocket expenses paid
by Celera to Third Parties for such assistance, in the defense or settlement of
such claim. AB will have sole authority to defend and/or settle any claim under
this Section 16. AB’s obligations under this Section 16 are
contingent upon Celera’s compliance with all of the foregoing.


 


16.3                          Remedy for
Infringement, Rights of AB, Exceptions. If any Product or portion
thereof is subject to a suit or other legal proceeding claiming that the
Product or such portion infringes a Third Party’s Intellectual Property Right,
or in AB’s opinion is likely to become 


 


[***] indicates material that has been
omitted pursuant to a request for confidential treatment. The omitted material
has been filed separately with the Securities and Exchange Commission.


 


22

















 


 


subject of such a claim, AB will, at its
option, have the right to either: (a) procure for Celera the right to
continue using the Product; or (b) modify the Product so that it becomes
non-infringing; or (c) require Celera to return the Product and upon
return, refund to Celera the price actually paid by Celera for the Product,
less a reasonable amount for use, damage and obsolescence; or (d) substitute
for the alleged infringing Product other suitable, non-infringing Products with
comparable functionality.


 


16.4                          ENTIRE
LIABILITY. EXCEPT AS OTHERWISE PROVIDED HEREIN, THE FOREGOING STATES THE ENTIRE
LIABILITY OF AB, AND THE EXCLUSIVE REMEDY OF CELERA, FOR ANY INFRINGEMENT OR
CLAIMED INFRINGEMENT OF PATENT, COPYRIGHT, TRADE SECRET OR ANY OTHER INTELLECTUAL
PROPERTY RIGHT BY OR IN CONNECTION WITH ANY PRODUCT.


 


16.5                          By Celera for
Celera’s Modifications or Specifications.
If Celera modifies any Product or furnishes AB with specifications or designs
or requests for specific labeling or branding, Celera agrees to defend,
indemnify and hold AB harmless against all liabilities, damages, costs,
expenses and claims asserted by a Third Party
against AB or any of its Affiliates arising from or based upon Celera’s
modifications or AB’s manufacture and sale of Product or other performance in
compliance with such specifications or designs or requests for labeling or
branding.


 


17           Product Recall


 


17.1                          Product Recall and Corrective
Actions. In the event
that: (a) any government authority issues a request, directive or order
that any Product be recalled; (b) a court of competent jurisdiction orders
such a recall; or (c) Celera and AB determine that any Product should be recalled
because of a regulatory requirement, the Product did not conform to applicable
Specifications, a manufacturing defect by
AB or a defect in materials and workmanship when the Product was delivered to
Celera, then each Party will take reasonable and appropriate corrective
actions consistent with its quality procedures and with the intent and purposes
of this Agreement. Each Party will
immediately notify the other Party telephonically, followed by notice in
writing, of any order, request or directive of a court or other governmental
authority to recall or withdraw a Product in any jurisdiction. AB will be
solely responsible and liable for the costs (including, but not limited to,
costs of notification and all costs of shipment of the recalled Products) of
implementing any recall or withdrawal of any Product, and for the cost of any replacement Products or
refunds required to be given to any end user customer of any Product, to the
extent the recall is caused by (i) a manufacturing defect by AB or a defect
in materials and workmanship when the Product was delivered to Celera or (ii) the
material breach by AB of any of its obligations, representations, warranties
(except Product warranties set forth in Section 13) and covenants set
forth in this Agreement, except for such breaches as to which the exclusive
remedies, identified as such, are expressly set forth elsewhere in this
Agreement. Celera will be responsible, at its sole cost and expense, for the
costs of implementing any recall or withdrawal of Products, in all other
circumstances. For the avoidance of doubt, AB will be responsible and liable
for such costs of recall on account of a Defective Item or such a defect in
materials and workmanship regardless of whether the date of recall was during
or after any applicable Product warranty period. Except as expressly stated
above in this Section 17.1 and elsewhere in this Agreement where AB will
indemnify Celera, it is expressly 


 


[***] indicates material that has been
omitted pursuant to a request for confidential treatment. The omitted material
has been filed separately with the Securities and Exchange Commission.


 


23

















 


 


understood and agreed that
Celera, not AB, will be solely responsible and liable for all costs and
liability arising out of any recall not due to AB’s gross negligence or willful
misconduct, as and to the extent set forth in Section 15.1. Celera will be
solely responsible for the text of any statement to be provided to customers.
Notwithstanding the foregoing, no statement regarding any recall that
identifies AB or any of its affiliates, directly or indirectly, by name or by
any other reference (such as “as manufacturer or supplier”) will be disclosed
to any Third Party except with AB’s prior written consent, which will not be
unreasonably withheld or delayed. In the event of a recall for which AB is
responsible as set forth in this Section 17.1 with respect to which (i) Celera
is required under law or contract to, or (ii) the Parties agree in writing,
in accordance with Celera’s normal course of business consistently applied, to,
refund the full purchase price to a customer and/or provide a customer with a
substitute product, AB will reimburse to Celera the transfer price to Celera of
any Products subject to such recall and with respect to which Celera has
refunded the full purchase price of the Product to its customer. Any Products
that are recalled will be returned by Celera to AB. AB will pay Celera any
amount due pursuant to this Section 17.1 within 30 days of receipt of an
invoice from Celera therefor, or, if the amount is disputed by AB, within 30
days of a final determination of the amount due. Any such invoice will include
reasonable documentation to support such charges. If the Parties do not agree
on the amount due, the amount due will be determined under the dispute
resolution procedures set forth in the Separation Agreement.


 


18           Confidentiality


 


18.1                          Confidentiality. At any time during the course of this
Agreement the Parties may disclose to one another, whether verbally or in
documentary form, information deemed by the disclosing Party to be confidential
(“Confidential Information”). This
Confidential Information may include, without limitation, pricing, data,
specifications, formula, diagrams, schematics, Know-how, Product volumes both
current and forecasted, business and financial information and marketing plans.
Confidential Information must be either clearly marked and identified as such
upon its disclosure or, where only identified verbally at time of disclosure,
confirmed in writing to the receiving Party as Confidential Information within
30 days. The receiving Party will not disclose Confidential Information to any
Third Party or use it for any purpose, in each case except as allowed under and
consistent with this Agreement, and will take all reasonable measures to
protect its confidentiality. These obligations of confidentiality will continue
for a period of five years following termination or expiration of this
Agreement, except with respect to Confidential Information that are trade
secrets, in which case the obligation of confidentiality will continue until
the trade secrets lose their status as such due to no fault of the receiving
Party. Excluded from Confidential Information is any information that (a) is
or becomes public knowledge through no fault of the receiving Party, (b) the
receiving Party can demonstrate through clear documentary evidence was known to
it prior to receipt and not covered by an obligation of confidentiality in
favor of the disclosing Party, (c) was subsequently received from a Third
Party without any obligation of confidentiality, or (d) is independently
developed by the receiving Party without use of Confidential Information, as
can be demonstrated by clear documentary evidence. This section will survive
the termination or expiration of this Agreement.


 


[***] indicates material that has been
omitted pursuant to a request for confidential treatment. The omitted material
has been filed separately with the Securities and Exchange Commission.


 


24

















 


 


19                                 Intellectual
Property


 


19.1                          As between the parties the
ownership of and rights in their respective intellectual property will be
determined in accordance with the provisions of the Separation Agreement.


 


20                                 Trademarks


 


20.1                          As between the parties the
ownership of and rights in their respective trademarks will be determined in
accordance with the provisions of the Separation Agreement.


 


20.2                          No rights to any AB trademark
are transferred to Celera under this Agreement.


 


21                                 Insurance


 


21.1                          AB will, at its own expense,
provide and maintain insurance for Worker’s Compensation; employer’s liability
for bodily injury suffered through accident or disease; and commercial general
liability, provided that in no event will AB carry coverage with limits of less than $2 million per occurrence for
bodily injury and $2 million per occurrence for property damage.


 


21.2                          AB will furnish Celera
certificates of insurance evidencing the required coverage and the insurer’s
agreement to provide 30 days’ prior written
notice to Celera in the event of cancellation or material change in coverage.
AB’s insurance policies will also name Celera as an additional insured with
coverage for Celera at least as broad as provided to AB for liability arising
out of Products supplied pursuant to this Agreement.


 


21.3                          The liability of AB will not
be limited to the amount of insurance which AB is required to provide by the
terms of this Section 21.


 


22                                 General


 


22.1                          Independent
Contractor. The relationship of AB to Celera hereunder is that of an
independent contactor. In no event will either Party hold itself out to others
or allow itself to be considered an agent, employee, or representative of the
other.


 


22.2                          Assignment.
Neither Party may assign or transfer its rights or obligations under this
Agreement or any document relating to this Agreement to any other entity or
person without the prior written consent of the other Party, except that
without the prior written consent of the other Party either Party after written
notice to the other Party may assign this Agreement to any Affiliate of either
Party and to any Party that is the successor to the business and operations of
such Party to which this Agreement relates, or in connection with the merger or
consolidation of the Party, provided that (i) the assigning Party will remain
primarily liable for the assignor’s obligations and covenants in this Agreement
and the assignee and assignor will agree in a writing delivered to the
non-assigning Party that the assignee and assignor will be jointly and
severally liable for the performance of the assignor’s and assignee’s covenants
and obligations in this Agreement and (ii) no Confidential Information of the
assigning Party that has been retained by the Assignor for evidentiary purposes
under Section 14, or that a Party is permitted to retain only for evidentiary
purposes under Section 14, will be delivered or made accessible to the assignee.


 


[***] indicates material that has
been omitted pursuant to a request for confidential treatment. The omitted
material has been filed separately with the Securities and Exchange Commission.


 


25














 


 


Any purported assignment in violation of the above will be null and
void and of no force and effect. Subject to the foregoing, this Agreement will
be binding upon and inure to the benefit of the Parties and their respective
successors and permitted assigns.


 


22.3         Governing
Law. This Agreement is deemed to be made under and will be construed
in accordance with the laws of the State of Delaware without giving effect to
any choice of law rule that would cause the application of the laws of any
jurisdiction other than the internal laws of the State of Delaware.


 


22.4         Notices.
All notices required hereunder will be in writing and will be sent by (a) U.S.
mail (first class), (b) nationally recognized courier service (e.g., DHL,
Federal Express), with all postage or delivery charges prepaid, or (c) facsimile,
subject to confirmation via U.S. mail or nationally recognized courier service,
and will be addressed to the Parties at their addresses set forth on the cover page of
this Agreement or to such other addresses as may be furnished by written notice
in the manner set forth herein.


 


22.5         Publicity.
Neither Party will advertise or otherwise disseminate by written or oral
publication the existence of this Agreement, or its terms, without the other
Party’s prior written consent, including as to the text thereof, which consent
will not be unreasonably withheld or delayed.


 


22.6         Force
Majeure. Failure of either Party to perform its obligations under
this Agreement (except for the obligation to make payments) will not subject
such Party to any liability to the other Party and will not be deemed a breach
of this Agreement if such failure is caused or occasioned by act of God
(including, without limitation, flood, drought, earthquake), act of a public
enemy including terrorist acts, fire, explosion, war, riot, insurrection,
sabotage, embargo, strike or other labor trouble, power outages or reductions,
failure of AB’s sole sourced suppliers (except where the product supplied is
available from other suppliers on reasonable commercial terms) to deliver on
schedule materials, equipment or machinery for reasons solely due to their own
force majeure (as defined herein), compliance with any order, regulation or
request of any government, administrative or regulatory entity acting with
color of right or any officer, department, agency or committee thereof, or by
any other event or circumstance beyond the reasonable control of the Party so
failing (“Force Majeure Events”). The affected
Party will promptly notify the other Party in writing setting forth the details
of the occurrence of force majeure, its expected duration and how that Party’s
performance is affected, and will use commercially reasonable efforts to resume
performance as soon as possible.


 


22.7         Agreement
Terms Govern. Although the Parties may use a Purchase Order or
whatever other form of writing they select from time to time to quote or order
Products, this Agreement will supersede and fully replace any different,
additional or conflicting terms, including without limitation all preprinted or
other standard terms (other than the name or identity of Products purchased,
quantity, delivery dates, bill to, ship to and invoice addresses and price) on (i) any
quotations, order confirmations, invoices or related documents issued during
the term or any extended term of this Agreement by AB or (ii) any purchase
orders or other related documents issued during the term or extended term of
this Agreement by Celera. Any different, additional or conflicting terms and
conditions in any such documents will be void and of no force and effect unless
agreed to in a writing signed by an authorized representative of each of Celera



 


[***] indicates material
that has been omitted pursuant to a request for confidential treatment. The
omitted material has been filed separately with the Securities and Exchange
Commission.


 


26

















 


 


and
AB that expressly states that such different, additional or conflicting terms
and conditions are intended to supersede the terms of this Agreement.


 


22.8         Entire
Agreement. No agreement or understanding in any way modifying these
terms and conditions, either before or after the execution hereof, will be
binding upon either Party unless in writing and signed by both Parties. This
Agreement and the other Separation Documents (as defined in the Separation
Agreement) constitute the entire agreement between the Parties with respect to
the subject matter of this Agreement, and supersede any prior or
contemporaneous communications, with respect to the subject matter hereof and
thereof. For the avoidance of doubt, the agreements between the Parties to be
entered for the supply of the 3100 Genetic Analyzer, among other things, and
the Kauai Project goods will not be merged into this Agreement and will remain
in full force and effect under their own distinct terms and conditions.


 


22.9         Waiver.
Failure by either Party to insist upon strict performance of any of the terms
and conditions hereof, or delay in exercising any rights or remedies provided
herein, will not release the other Party from any of the obligations of this
Agreement and will not be deemed a waiver of any rights of such other Party to
insist upon strict performance thereof.


 


22.10       Severability.
If any one or more of the provisions contained in this Agreement is, for any
reason, held to be invalid, illegal or unenforceable in any respect, such
invalidity, illegality or unenforceability will not affect any other provision
hereof, and this Agreement will be construed as if such invalid, illegal or
unenforceable provision had never been contained herein.


 


22.11       Headings.
Headings used in this Agreement are for convenience of reference only and will
not affect the interpretation of this Agreement.


 


22.12       Counterparts.
This Agreement may be executed in two or more counterparts, each of which
counterparts, when duly executed and delivered, will be deemed to be an
original and all of which counterparts, taken together, will constitute one and
the same Agreement.


 


IN
WITNESS WHEREOF, the Parties have caused their duly authorized representatives
to execute and deliver this Agreement as of the Effective Date.


 


	
  APPLERA
  CORPORATION

  	
   

  	
  CELERA
  CORPORATION

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  By:

  	
   

  	
   

  	
  By:

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Name:

  	
   

  	
   

  	
  Name:

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Title:

  	
   

  	
   

  	
  Title:

  	
   

  
								



 


 


[***] indicates material that has been omitted pursuant to a request
for confidential treatment. The omitted material has been filed separately with
the Securities and Exchange Commission.


 


27

















 


 


	
  Date:

  	
   

  	
   

  	
  Date:

  	
   

  



 


 


[***] indicates material
that has been omitted pursuant to a request for confidential treatment. The
omitted material has been filed separately with the Securities and Exchange
Commission.


 


28














 


Exhibit A


 


Assumptions &
Definitions


 


	
  Attachment
  A only contains items that Celera has procured in the last [**].

  
	
   

  	
   

  
	
  Expire to Ship(ETS)

  	
  Product
  DOES NOT have an expiration date on it.

  
	
   

  	
  Product
  is warranted for 1 year from shipment date.

  
	
   

  	
   

  
	
  Expire to Use(ETU)

  	
  Product DOES have an expiration on it.

  
	
   

  	
  Product
  may ship with 2 months remaining dating.

  
	
   

  	
   

  
	
  Topfills

  	
  Items
  noted as Topfills contain multiple items.

  
	
   

  	
  Topfills
  do not have expiration or warranties.

  
	
   

  	
  Components
  of Topfills have expiration or warranties.

  
	
   

  	
  Components
  of Topfills should be added to the Master List.

  
	
   

  	
  Celera
  can order components or topfills unless otherwise stated.

  
	
   

  	
   

  
	
  Components
  of Topfills are listed under the parent and the parent part number is in the
  Celera description.

  
	
  Components
  of Topfills shaded in BLUE are duplicates

  
	
   

  	
   

  
	
  Order Types

  	
  Off the
  Shelf(OTS). Standard products that are maintained in inventory.

  
	
   

  	
  Products
  are typically available same day as order is placed.

  
	
   

  	
   

  
	
   

  	
  Make to
  Order(MTO). Products are only produced when a firm order(PO) is received.

  
	
   

  	
  Leadtimes
  vary product by product.

  



 






[**] indicates material that
has been omitted pursuant to a request for confidential treatment. The omitted
material has been filed separately with the Securities and Exchange Commission.


 















 


	
  Internal Mfg

  or

  Purchased

  	
   

  	
  AB Part

  Number

  	
   

  	
  AB Description

  	
   

  	
  Celera Description

  	
   

  	
  Order

  Type

  	
   

  	
  Expiry

  	
   

  	
  Leadtime

  (Calendar

  Days)

  	
   

  	
  AB Comments

  	
   

  	
  

  

  Celera Comments

  	
   

  	
  Qty ship

  in last 5

  years

  	
   

  	
  Date of last

  shipment

  
	
  Purchased

  	
   

  	
  5402

  	
   

  	
  BUFFER,JAR 9ML

  	
   

  	
  Anode buffer reservoir

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  400060

  	
   

  	
  FG,ANHYDROUS ACETONITRILE 30mL

  	
   

  	
  Anhdrous Acetonitrile 30 mL

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  400142

  	
   

  	
  FG,DCM,PEPTIDE SYNTHESIS 4L

  	
   

  	
  Dichloromethane, HPLC Grade

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  400236

  	
   

  	
  FG,TCA (CH2-C12)/DCM, 450mL

  	
   

  	
  Deblocking Sol (TCA/Dic)

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  400326

  	
   

  	
  FG,CE-PHOSPHORAMIDITE A 1g

  	
   

  	
  CE Phosphoramidite A

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  400327

  	
   

  	
  FG,CE-PHOSPHORAMIDITE G 1g

  	
   

  	
  Phosphoramidite, G 1g (400327)

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  400328

  	
   

  	
  FG,CE-PHOSPHORAMIDITE C 1g

  	
   

  	
  CE Phosphoramidite C

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  400329

  	
   

  	
  FG,CE-PHOSPHORAMIDITE T 1g

  	
   

  	
  CE Phosphoramidite T

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  400445

  	
   

  	
  FG,TRIFLUOROACETIC ACID, 10ml

  	
   

  	
  TFA HPLC Grade

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  400613

  	
   

  	
  FG,TRIETHYLAMINE ACETATE 2M,200mL

  	
   

  	
  TRIETHYLAMINE ACETATE 2M,200mL

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  400945

  	
   

  	
  COL,1 umol A CPG

  	
   

  	
  dA CPG

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  400946

  	
   

  	
  COL,1 umol C CPG

  	
   

  	
  dC CPG

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  400948

  	
   

  	
  COL,1 umol T CPG

  	
   

  	
  T CPG

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  401087

  	
   

  	
  FG,ACETONITRILE DNA/RNA 4L

  	
   

  	
  Anhydrous Acetonitrile

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  401114

  	
   

  	
  DYE PRIMER/GS MATRIX STDS

  	
   

  	
  Dye Primer Matrix Standars

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  401159

  	
   

  	
  FG,CE-PHOSPHORAMIDITE A / 2.0g^

  	
   

  	
  PHOSPHORAMIDITE “A” 1g

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  401160

  	
   

  	
  FG,CE-PHOSPHORAMIDITE C / 2.0g

  	
   

  	
  RM, DMT-dCytidine Amidite

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  401162

  	
   

  	
  CE-PHOSPHORAMIDITE T / 2.0g

  	
   

  	
  T AMIDITE 2G

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  401165

  	
   

  	
  FG,dG(DMF) FASTPHORAMIDITE 2.0g

  	
   

  	
  RM, dG (DMF) Fastphoramidite

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  401183

  	
   

  	
  FG,dG(DMF) FASTPHORAMIDITE, 1.0gr

  	
   

  	
  CE Phosphoramidite G

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  401438

  	
   

  	
  COLUMN, WP dA(Bz) - 1umol

  	
   

  	
  CPG Columm A

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  401445

  	
   

  	
  Anhydrous Acetonitrile, 100mL

  	
   

  	
  Anhydrous Acetonitrile, 100mL

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  401527

  	
   

  	
  6-FAM AMIDITE, 85mg

  	
   

  	
  6-FAM AMidite (85mg)

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  401546

  	
   

  	
  FLUOR AMIDITE MATRIX STDS

  	
   

  	
  Flourescent Amidite Matrix Standa

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  401717

  	
   

  	
  PHOSPHALINK,70mg

  	
   

  	
  Phosphorylating RGNT, 5’ (401717)

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  401736

  	
   

  	
  KIT,PRISM GENESCAN 350 TAMRA

  	
   

  	
  Genescan 350 TAMRa Std

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  401846

  	
   

  	
  TAQMAN,B-ACTIN DETECTION RGNTS

  	
   

  	
  TAQMAN BACTIN DET. REAGENT

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  402014

  	
   

  	
  KIT,AFLP MseI-CTT OLIGO-250uL

  	
   

  	
  MSE1-CTT primer

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  402015

  	
   

  	
  KIT,AFLP Mse-CTG OLIGO-250uL

  	
   

  	
  Mge1CTG primers

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  402017

  	
   

  	
  KIT,AFLP Mse-CTA OLIGO-250uL

  	
   

  	
  MSE1 CTA primer

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  402038

  	
   

  	
  KIT,AFLP ECO RI-ACA FAM-250uL

  	
   

  	
  EcoRI-ACA FAM

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  402045

  	
   

  	
  KIT,AFLP ECO RI-ACT FAM-250uL

  	
   

  	
  EcoRI-ACT FAM

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  402152

  	
   

  	
  FG,DCM,DNA SYNTHESIS,2L

  	
   

  	
  Dichloromethane, HPLC Grade 2L

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  402264

  	
   

  	
  AFLP ECO RI-TG FAM,250uL

  	
   

  	
  EcoRI-TG FAM

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  402824

  	
   

  	
  FG,BUFFER (10X) WITH EDTA 25ML

  	
   

  	
  10xbuffer w/EDTA ABI

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  402996

  	
   

  	
  NED MATRIX STANDARD KIT

  	
   

  	
  NED Matrix Standard Kit

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  403046

  	
   

  	
  KIT,dRHOD. MATRIX STDS

  	
   

  	
  KIT,dRHOD. MATRIX STDS

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  403055

  	
   

  	
  BOX,BDP TAQ FS RR-100-21M13

  	
   

  	
  Big Dye Primer Cycle Seq. Kit

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  403081

  	
   

  	
  9700 MicroAmp 96-well Tray/Retainer set

  	
   

  	
  Tray/retainer set

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  403170

  	
   

  	
  HEX AMIDITE,55mG

  	
   

  	
  FG HEx Amidite (55 mg)

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  403171

  	
   

  	
  TET AMIDITE,50mG

  	
   

  	
  TET Amidite 50 mg

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  450025

  	
   

  	
  TaqMan TAMRA PROBE 6,000 PMOLES

  	
   

  	
  TaqMan TAMRA PROBE 6,000 PMOLES

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Custom oligo

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4303326

  	
   

  	
  AmpFLSTR Profiler Plus PCR Kit

  	
   

  	
  AmpF/STR Porfiler Plus PCR Amplification Kit

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4304437

  	
   

  	
  FG,TAQMAN PCR MASTER MIX,MNL 4304449

  	
   

  	
  Taqman Universal PCR Mix

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4304470

  	
   

  	
  ASSY,SYRINGE 250UL W/SEAL KLOEHN

  	
   

  	
  ASSY,SYRINGE 250UL W/SEAL KLOEHN

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4304970

  	
   

  	
  SEQUENCE DETECTION PRIMER, 10,000 PICOMO

  	
   

  	
  primer probe (Sequence Detection Primer)

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Custom oligo

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4305545

  	
   

  	
  FG,ABSOLUTE RNA WASH SOLUTION

  	
   

  	
  ABSOLUTE RNA WASH 6X10ML

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4305603

  	
   

  	
  FG,5X SEQUENCING BUFFER 5400 RXN

  	
   

  	
  5X SEQ BUFFER

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4305822

  	
   

  	
  FG,SDS SPECTRAL CALIBRATON KIT

  	
   

  	
  SPECTRAL CALIB KIT FOR 7700 SDS

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4306311

  	
   

  	
  MicroAmp Clear Adhesive Film, 100 pc

  	
   

  	
  MicroAmp Clear Adhesive Film, 100 pc

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4306733

  	
   

  	
  FG, BTL 3700 DNA ANALYSIS POLYMER

  	
   

  	
  3700 POP-6 Polymer 210 ml bo

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4306733

  	
   

  	
  FG, BTL 3700 DNA ANALYSIS POLYMER

  	
   

  	
  3700 Pop 6 Polymer 210mL

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4306737

  	
   

  	
  FG,TCII REACTION PLT,96 WELL,BARCODE,KIT

  	
   

  	
  FG,TCII REACTION PLT,96 WELL,BARCODE,KIT

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4306819

  	
   

  	
  ASSY,OPTICAL CALIB PLATE GRN

  	
   

  	
  Assy, optical calib plate grn

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4306898

  	
   

  	
  FG,GA 10xPCR GLD BUFF&MgCl2,6x1.5mL

  	
   

  	
  10x PCR Gold Buffer, 6x1.5 ml

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4306902

  	
   

  	
  RM,GA 10x PCR GOLD BUFF&MgCl2,150mL

  	
   

  	
  10X PCR Gold Buffer

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4309849

  	
   

  	
  FG,384-WELL CLEAR RXN PLATE

  	
   

  	
  384 well opti. react. plate

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4311320

  	
   

  	
  FG,HI-DI FORMAMIDE 25mL BOTTLE

  	
   

  	
  Hi-Di Formamide

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4311320

  	
   

  	
  FG,HI-DI FORMAMIDE 25mL BOTTLE

  	
   

  	
  HI-DI FORMAMIDE 25mL BOTTLE

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4311806

  	
   

  	
  FG,AMPLITAQ GOLD 250U+GOLD BUFFER+MgCI2

  	
   

  	
  Ampl. Taq Gold DNA Polymerase

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4311816

  	
   

  	
  FG,AMPLITAQ GOLD 1000U+GOLD BUFFER+MgCI2

  	
   

  	
  AmpliTaq Gold DNA Poly Kit, 1000

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4311818

  	
   

  	
  FG,AMPLITAQ GOLD 5X1000U+GOLD BUFFER+MgC

  	
   

  	
  AMPLITAQ GOLD DNA POLYMERASE

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4311971

  	
   

  	
  FG,OPTICAL ADHESIVE COVERS

  	
   

  	
  Microamp optical adhesive cover

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4312063

  	
   

  	
  96-well Splash Free Support Base

  	
   

  	
  96-well base

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4313663

  	
   

  	
  FG, OPTICAL ADHESIVE COVERS STARTER KIT

  	
   

  	
  Optical Adhesive Cover Starter Ki

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4315931

  	
   

  	
  FG,CAPILLARY ARRAY 16 x 36cm

  	
   

  	
  FG,CAPILLARY ARRAY 16 x 36cm

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4315933

  	
   

  	
  SEPTA STRIP,96 WELL TRAY

  	
   

  	
  SEPTA STRIP,96 WELL TRAY

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4316032

  	
   

  	
  TaqMan MGB PROBE 50,000 PMOLES

  	
   

  	
  Taqman MGB probe 50,000

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Custom oligo

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4316033

  	
   

  	
  TaqMan MGB PROBE 20,000 PMOLES

  	
   

  	
  TaqMan MGB PROBE 20,000 PMOLES

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Custom oligo

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4316034

  	
   

  	
  TaqMan MGB PROBE 6,000 PMOLES

  	
   

  	
  Custom TagMan MGB Probes

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Custom oligo

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4316355

  	
   

  	
  FG,3100 POP4

  	
   

  	
  3100 PERFORMANCE OPT. POLYMER 4

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4316357

  	
   

  	
  FG,3100 POP6

  	
   

  	
  ML POP6 FOR 3100

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4316357

  	
   

  	
  FG,3100 POP6

  	
   

  	
  POP6 Polymer

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4316831

  	
   

  	
  FG,TQMN RNASE P DETECT RGTS(FAM)100 RXS

  	
   

  	
  Taqman Rnase P detection reagent

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4318157

  	
   

  	
  FG,TAQMAN UNIVERSAL PCR MSTR MX 2000 RXN

  	
   

  	
  TAQMAN UNIVERSAL PCR MMX 2000 R

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4318976

  	
   

  	
  FG,3700 RUN BUFFER,4L

  	
   

  	
  3700 Running Buffer w EDTA 4L

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4318986

  	
   

  	
  FG,PET-2 AMIDITE, 120 mg

  	
   

  	
  FG, PET-2 AMIDITE, 120 mg

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4322288

  	
   

  	
  AmpFLSTR Identifiler PCR Kit

  	
   

  	
  Amp f/STR Identifier PCR Amplification Kit

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4322682

  	
   

  	
  FG,GENESCAN-500(LIZ) SIZE STD KIT

  	
   

  	
  GeneScan 500 LIZSize

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  



 


















 


	
  Internal Mfg

  or

  Purchased

  	
   

  	
  AB Part

  Number

  	
   

  	
  AB Description

  	
   

  	
  Celera Description

  	
   

  	
  Order

  Type

  	
   

  	
  Expiry

  	
   

  	
  Leadtime

  (Calendar

  Days)

  	
   

  	
  AB Comments

  	
   

  	
  

  

  Celera Comments

  	
   

  	
  Qty ship

  in last 5

  years

  	
   

  	
  Date of last

  shipment

  
	
  Internal Mfg

  	
   

  	
  4323014

  	
   

  	
  FG,3100/3130 MATRIX STD SET DS-02

  	
   

  	
  SNaPshot Matirx Standard Set

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4323032

  	
   

  	
  FG,OPTICAL CAP (8 CAPS/STRIPS)

  	
   

  	
  8 caps per strip Optical Caps

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4323306

  	
   

  	
  FG,384 WELL RNASE P INST VERIF PLATE

  	
   

  	
  384 Well Rnase Test Plate

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4323977

  	
   

  	
  FG,384 WELL DYE CALIBRATION PLATE KIT

  	
   

  	
  Spectral Calibration Kit 384

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4324018

  	
   

  	
  FG,TAQMAN UNIVERSAL PCR MSTR MIX,NO UNG

  	
   

  	
  TAQMAN UNIV.TAQMAN PCR MIX

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4328639

  	
   

  	
  FG,96 WELL DYE CALIBRATION PLATE KIT

  	
   

  	
  Sequence Detection Systems 96-Well Spectral
  Calibration Kit

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4328895

  	
   

  	
  FG,7000 SPECTRAL DYE CALIB KIT

  	
   

  	
  ABI PRISM 7000 Seqe Detect Sstms

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4329538

  	
   

  	
  FG,SNAPSHOT PRIMER FOCUS

  	
   

  	
  Primers Focus Kit

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4331182

  	
   

  	
  FG,OFF THE SHELF GX SET

  	
   

  	
  Off the Shelf GX Set

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
  [**]

  	
   

  	
  Generic part

  number for

  AOD GX.

  Actual assay

  ID’s do have

  expiration date

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4332073

  	
   

  	
  CUSTOM TaqMan SNP ASSAY HUMAN LARGESCALE

  	
   

  	
  Assays by Design

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Custom oligo

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4333183

  	
   

  	
  FG,ADHESIVE SEAL APPLICATOR KIT(BAG=5)

  	
   

  	
  FG, Adhesive Seal Applicator Kit (Bag=5)

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4335613

  	
   

  	
  FG,3730 Buffer(10X) with EDTA 500mL

  	
   

  	
  10x Running Buffer 500 ml

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4336697

  	
   

  	
  TUBE,5X SEQ BUFFER SMALL

  	
   

  	
  Big Dye Terminator

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4336699

  	
   

  	
  BTL,5X SEQ BUFFER MEDIUM

  	
   

  	
  BTL, 5 x Seq Buffer Medium (28ml)

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4336774

  	
   

  	
  FG,BDT v1.1 RR-100 KIT

  	
   

  	
  BDT v1.1 Cycle Sequencing kit

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4336791

  	
   

  	
  FG,BDT v1.1 SEQ STD KIT

  	
   

  	
  sequencing standard kit BDT v1.1

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4336799

  	
   

  	
  FG,37XX BDT v1.1 SEQ STD KIT

  	
   

  	
  3700 Big Dye Terminator Sequence

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4336935

  	
   

  	
  FG,BDT v3.1 SEQ STD KIT

  	
   

  	
  3130x1 Big Dye 3.1 Sequencing

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4336943

  	
   

  	
  FG,37XX BDT v3.1 SEQ STD,KIT

  	
   

  	
  FG,37XX BDT v3.1 SEQ STD,KIT

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4336974

  	
   

  	
  KIT,3100/3130 BDT v3.1 MTX STDS

  	
   

  	
  Matrix Standard Kit BDT 3.1

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4336975

  	
   

  	
  KIT,3700 BDT v3.1 MTX STDS

  	
   

  	
  3700 MATRIX STANDARD

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4338543

  	
   

  	
  FG,ICAT CLEAVING REAGENT- A

  	
   

  	
  Cleavable ICAT Reagent A

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4342718

  	
   

  	
  Sample Block Module, 9700 Dual 96-w

  	
   

  	
  Sample Block Module, 9700 Dual

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4343369

  	
   

  	
  FG,384 WELL CLR RX PLT W/BRCD BULK PK

  	
   

  	
  FG, 384 well clear RX plate

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4343895

  	
   

  	
  Quantifiler Human DNA kit

  	
   

  	
  Quantifiler® Human DNA Quantification Kit

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4344409

  	
   

  	
  FG,6-FAM AMIDITE, 1.0g

  	
   

  	
  FG,6-FAM AMIDITE, 1.0g

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Custom. Made

  only for Celera.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4344668

  	
   

  	
  FG,6-FAM NHS ESTER 100MG

  	
   

  	
  RM, NHS ester, 6-Fam

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4344675

  	
   

  	
  FG,HUMAN DNA MALE 50mL

  	
   

  	
  FG,HUMAN DNA MALE 50mL

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4344676

  	
   

  	
  FG,LOADING BUFFER 500mL

  	
   

  	
  Loading Buffer Bulk

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4345827

  	
   

  	
  FG,DS-30 (DYE SET D) MATRIX STD KIT

  	
   

  	
  DS-30 (dye set D) matrix

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4345833

  	
   

  	
  FG,DS-33 (DYE SET G5) MATRIX STD KIT

  	
   

  	
  DS-33 matrix standard kits

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4346305

  	
   

  	
  OEM,BULK PASSIVE REFERENCE STD

  	
   

  	
  RM, Fret ROX (1 mL)

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4346498

  	
   

  	
  FG,BUFFER TAQ CSA 5X

  	
   

  	
  Buffer Taq CSA 5x (361028C)

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Custom. Only

  for Celera.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4346504

  	
   

  	
  FG,PASSIVE REFERENCE STD ROX

  	
   

  	
  RM, Passive Reference Standard (ROX)

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4346993

  	
   

  	
  TUBES,0.2ML WITH CAP,IVD

  	
   

  	
  MicroAmp Tubes with caps, IVD

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Custom. Only

  for Celera.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4349690

  	
   

  	
  TUBES,0.2ML WITH CAP, CE

  	
   

  	
  MicroAmp Tubes with caps, CE

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Custom. Only

  for Celera.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4350584

  	
   

  	
  FG,96 WELL RNASE P VERIF PLATE NO PAD

  	
   

  	
  7300 & 7500 Taqman RNaseP

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4351151

  	
   

  	
  7500 SPECTRAL RED DYE CAL KIT

  	
   

  	
  7500 Calibration Kit II

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4351372

  	
   

  	
  KIT,TQMN GENE EX ASSAYS, SM

  	
   

  	
  TaqMan® Gene Expression Assays

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Custom oligo

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4351379

  	
   

  	
  TaqMan PRE-DESIGNED SNP GENOTYPING ASSAY

  	
   

  	
  TaqMan PRE-DESIGNED SNP GENOTYPING ASSAY

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Custom oligo

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4351389

  	
   

  	
  FG,96 WELL MICROPLATE WITH COVERS IVD

  	
   

  	
  Optical 96-Well Plates w/Covers, IVD

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Custom. Only

  for Celera.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4351391

  	
   

  	
  FG,96 WELL MICROPLATE WITH COVERS CE

  	
   

  	
  Optical 96-Well Plates w/Covers, CE

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Custom. Only

  for Celera.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4351426

  	
   

  	
  OEM,BULK ROX PASSIVE REFERENCE STD

  	
   

  	
  RM, ROX - 6T

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4352755

  	
   

  	
  FG,3130 POP-4TM Polymer

  	
   

  	
  Pop 6 for 3130x1

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4352757

  	
   

  	
  FG,3130 POP-6TM Polymer

  	
   

  	
  PoP-6 Polymer 3170

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4352759

  	
   

  	
  FG,3130 POP-7TM Polymer

  	
   

  	
  3130 Pop-7 Performance

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4363785

  	
   

  	
  FG,3130 POP-7, 3.5ml

  	
   

  	
  POP-7 Polymer for 3130x1

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4368813

  	
   

  	
  Kit, High Capacity cDNA RT (1000 Rxns)

  	
   

  	
  High Capacity cDNA Kit

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4368814

  	
   

  	
  Kit, High Capacity cDNA RT (200 Rxns)

  	
   

  	
  Kit, High Capacity cDNA RT (200 Rxns)

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4369016

  	
   

  	
  FG,TAQMAN GEx MASTER MIX,5 ML

  	
   

  	
  FG, TaqMan Gex Master Mix, 5ml

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4371355

  	
   

  	
  FG,TAQMAN GT MASTER MIX,10 ML

  	
   

  	
  TaqMan Genotyping Master Mix

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4376486

  	
   

  	
  FG, BIGDYE XTERMINATOR KIT 2ML

  	
   

  	
  Big Dye XTerminator Purification

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4389167

  	
   

  	
  FG, BDT SEQUENCING RR MIX 245ML

  	
   

  	
  FG, BDT SEQUENCING RR MIX 245ML

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Custom. Only

  for Celera.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  361769C

  	
   

  	
  CUSTOM,ROX CPG

  	
   

  	
  RM, ROX CPG 1G

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Custom. Only

  for Celera.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4310592C

  	
   

  	
  CUSTOM,PRIMER -21M13 FWD (3.2uM)

  	
   

  	
   

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Celera was

  requesting

  internal use

  only part.

  Changed to

  custom part

  for Celera.

  Minimum &

  Maximum batch

  size is 100ml

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4310594C

  	
   

  	
  CUSTOM,PRIMER M13 REV (3.2u)

  	
   

  	
   

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Celera was

  requesting

  internal use

  only part.

  Changed to

  custom part

  for Celera.

  Minimum &

  Maximum batch

  size is 100ml

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4326320E

  	
   

  	
  FG,hu GUS MGB

  	
   

  	
  Human GUSB Endogenous Control

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4326502C

  	
   

  	
  CUSTOM,6-FAM AMIDITE

  	
   

  	
  6-FAM Amidite 1G

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Custom; not

  catalog.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4333767F

  	
   

  	
  FG,HUMAN GUSB

  	
   

  	
  Human GUSB Endogenous Control

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4335632C

  	
   

  	
  CUSTOM,PASSIVE REFERENCE

  	
   

  	
  FRETROX

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Custom.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4346516C

  	
   

  	
  CUSTOM,BENZYLDADENOSINE CPG

  	
   

  	
  RM, DMT Benzyl dAdenosine CPG

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Custom. Made

  only for Celera.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4366266C

  	
   

  	
  FG, cICAT CUSTOM REAGENT

  	
   

  	
  Poros custom/qte 20345424

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  AM1964

  	
   

  	
  RNaseAlert Lab Test Kit 25 assays

  	
   

  	
  RNaseAlert Lab Test Kit 25 assays

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  AM2548

  	
   

  	
  Proteinase K (20 mg/ml) 5 X 1.25 ml

  	
   

  	
  Proteinase K 20mg/ml

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  AM7244

  	
   

  	
  Human Liver Tumor/NAT Ttl RNA 5 ug ea

  	
   

  	
  Hum Liv tum

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  AM7245

  	
   

  	
  Human Liver Tumor Total RNA 5 ug

  	
   

  	
  HumLivr. tum.

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  AM9530G

  	
   

  	
  1 M Magnesium Chloride 100 ml (Buf Kit)

  	
   

  	
  Magnesium chloride 1.0 M

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  AM9680

  	
   

  	
  Salmon Sperm DNA (sheared) 10 x 10 mg

  	
   

  	
  Salmon Sperm DNA

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  N8010055

  	
   

  	
  GENEAMP KIT WITH AMPLITAQ-FROZ

  	
   

  	
  GENEAMP PCR KIT

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  



 


















 


	
  Internal Mfg

  or

  Purchased

  	
   

  	
  AB Part

  Number

  	
   

  	
  AB Description

  	
   

  	
  Celera Description

  	
   

  	
  Order

  Type

  	
   

  	
  Expiry

  	
   

  	
  Leadtime

  (Calendar

  Days)

  	
   

  	
  AB Comments

  	
   

  	
  

  

  Celera Comments

  	
   

  	
  Qty ship

  in last 5

  years

  	
   

  	
  Date of last

  shipment

  
	
  Purchased

  	
   

  	
  N8010531

  	
   

  	
  MicroAmp 96-well Support Base

  	
   

  	
  Microamp 96 well base

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  N8010534

  	
   

  	
  MicroAmp Caps, 12 Caps/Strip

  	
   

  	
  Optical 12-Cap Strip

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  N8010535

  	
   

  	
  MicroAmp Caps, 8 Caps/Strip

  	
   

  	
  MicroAmp 8-Strip Cap

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  N8010541

  	
   

  	
  9600/9700 MicroAmp Tray for Tubes w/Cap

  	
   

  	
  Tray MicroAmp

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  N8010550

  	
   

  	
  MicroAmp 96-well Full Plate Cover

  	
   

  	
  Microamp 96 well plate cover

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  N8010560

  	
   

  	
  MicroAmp 96-well Rxn Plate - no barcode

  	
   

  	
  MicroAmp 96-well Rxn Plate - no barcode

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  N8010580

  	
   

  	
  MicroAmp 8-Strip Rxn Tubes, 0.2mL

  	
   

  	
  MicroAmp 8-Tube Strip 0.2ml

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  N8080007

  	
   

  	
  GENEAMP DNTPS-FROZEN

  	
   

  	
  10MMDCTP, 10MMDATP, 10MMDGT

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  N8080018

  	
   

  	
  MULV REVERSE TRANSCRIPTASE

  	
   

  	
  MuLV Reverse Transcriptase

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  N8080096

  	
   

  	
  URACIL N-GLYCOSYLASE-FROZEN

  	
   

  	
  AmpErse (UNG)

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  N8080119

  	
   

  	
  RNase Inhibitor, 20 Units/ol, 100 Rxn

  	
   

  	
  RNase Inhibitor

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  N8080150

  	
   

  	
  AMPLIWAX PCR GEM 50

  	
   

  	
  Ampliwax PCR em 50

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  N8080158

  	
   

  	
  ATAQ LD + BUFFER II

  	
   

  	
  Amplitaq DNA LD w/buffer II

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  N8080159

  	
   

  	
  AmpliTaq DNA POLYMERASE300U/uL

  	
   

  	
  Amplitaq @ 300 units/ul

  	
   

  	
  MTO

  	
   

  	
  ETU

  	
   

  	
  [**]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  N8080160

  	
   

  	
  AMPLITAQ 250 UNIT VIAL-FRZN

  	
   

  	
  Amplitaq & buffer

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  N8080172

  	
   

  	
  ATAQ 1000 & BUFFER II

  	
   

  	
  AMPLITAQ 1,000U W/BUFFER

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  N8080179

  	
   

  	
  GENEAMP EZ WITH RNA PCR KIT

  	
   

  	
  Gene Amp EZ rTth RNA

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  N8080248

  	
   

  	
  AMPLITAQ GOLD 5x100OU BUFFER I

  	
   

  	
  Amplitaq Gold

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  N8080249

  	
   

  	
  AMPLITAQ GOLD 5x1000U BUF II

  	
   

  	
  AMPLITAQ GOLD 5 X 1,000 UNITS

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  N8080250

  	
   

  	
  BULK TAQ GOLD 25000U, 5mL

  	
   

  	
  Bulk Taq Gold 25000U, 5ml

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  N8080260

  	
   

  	
  FG,dNTP MIX w/dTTP,1mL,10mM

  	
   

  	
  GeneAmp dNTP Mix with dTTP

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  N8080270

  	
   

  	
  FG,dNTP MIX w/dUTP,1mL,12.5mM

  	
   

  	
  dNTP blend w/dUTP

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4308206

  	
   

  	
  Top Fill,GeneAmp Gold RNA PCR Reagent

  	
   

  	
  Geneamp Gold PCR kits

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4308207

  	
   

  	
  FG,GENEAMP GOLD RNA PCR CORE KIT

  	
   

  	
  4308206

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4308238

  	
   

  	
  Kit,GeneAmp RNA PCR Control Kit.

  	
   

  	
  4308206

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4310253

  	
   

  	
  PRTCL,GENEAMP GOLD RNA PCR RGNT KITZ

  	
   

  	
  4308206

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4322547

  	
   

  	
  TF,PREPMAN ULTRA

  	
   

  	
  Prep Man Reagent

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4318930

  	
   

  	
  FG,PREPMAN ULTRA

  	
   

  	
  4322547

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4367551

  	
   

  	
  QRC,ANUBIS PREPMAN ULTRA REAGENT

  	
   

  	
  4322547

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4367554

  	
   

  	
  PRTCL,ANUBIS PREPMAN ULTRA REAGENT

  	
   

  	
  4322547

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4337450

  	
   

  	
  TF,BDT v1.1 RR-100 & SEQ BUFFER

  	
   

  	
  Big Dye Terminator

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4336697

  	
   

  	
  TUBE,5X SEQ BUFFER SMALL

  	
   

  	
  4337450

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4336774

  	
   

  	
  FG,BDT v1.1 RR-100 KIT

  	
   

  	
  4337450

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4337451

  	
   

  	
  TF,BDT v1.1 RR-1000 & SEQ BUFFER

  	
   

  	
  BDT cycle sequencing kit. (1000 RR)

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4336776

  	
   

  	
  FG,BDT v1.1 RR-1000 KIT

  	
   

  	
  4337451

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4339843

  	
   

  	
  BTL,5X SEQ BUFFER 12mL

  	
   

  	
  4337451

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4337452

  	
   

  	
  TF,BDT v1.1 RR-5000 & SEQ BUFFER

  	
   

  	
  Bot v1.1 kit 5000rxn BDT

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4336699

  	
   

  	
  BTL,5X SEQ BUFFER MEDIUM

  	
   

  	
  4337452

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4336778

  	
   

  	
  FG,BDT v1.1 RR-5000 KIT

  	
   

  	
  4337452

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4337455

  	
   

  	
  TF,BDT v3.1 RR-100 & SEQ BUFFER

  	
   

  	
  Big Dye Terminator 3.1

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4336697

  	
   

  	
  TUBE,5X SEQ BUFFER SMALL

  	
   

  	
  4337455

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4336917

  	
   

  	
  FG,BDT v3.1 RR-100

  	
   

  	
  4337455

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4337457

  	
   

  	
  TF,BDT v3.1 RR-5000 & SEQ BUFFER

  	
   

  	
  BigDye terminator v3.1 cycl. seq

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4336699

  	
   

  	
  BTL,5X SEQ BUFFER MEDIUM

  	
   

  	
  4337457

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4336921

  	
   

  	
  FG,BDT v3.1 RR-5000

  	
   

  	
  4337457

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4338856

  	
   

  	
  TF,AMPLITAQ GOLD LD 250U KIT

  	
   

  	
  AmpliTaq Gold DNA Polyverasl

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4338859

  	
   

  	
  FG,AMPLITAQ GOLD LD 250U KIT

  	
   

  	
  4338856

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4316866

  	
   

  	
  TF,SEQUAZYME PEPTIDE MASS STD INSTL KIT

  	
   

  	
  Voyager Installation Standard

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  2-2158-00

  	
   

  	
  FG,SEQUAZYME BSA TEST STD (EA)

  	
   

  	
   

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  GEN602151

  	
   

  	
  FG,VOYAGER IgG1 MASS STANDARD

  	
   

  	
   

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  P2-3143-00

  	
   

  	
  FG,SEQUAZYME MASS STANDARDS KIT

  	
   

  	
   

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4323151

  	
   

  	
  TF,SNAPSHOT MULTIPLEX 100 RXN

  	
   

  	
  Snapshot Multiplex Kit

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4323159

  	
   

  	
  FG,SNAPSHOT MULTIPLEX 100 RXN

  	
   

  	
  4323151

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4323357

  	
   

  	
  PRTCL,SNAPSHOT VERSION 2

  	
   

  	
  4323151

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4323975

  	
   

  	
  QSC,SNAPSHOT VERSION 2

  	
   

  	
  4323151

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  AM1975

  	
   

  	
  RecoverAll(TM) Total NA Iso 40 rxn. 2 pt

  	
   

  	
  Recoverall Total Nucleic Acid

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill. Should

  be ordered as a

  topfill as

  components are

  a matched pair.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  1975-1

  	
   

  	
  RT part of 1975 RecoverAll(TM)

  	
   

  	
  AM1975

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  1975-2

  	
   

  	
  -20C part of 1975 RecoverAll(TM)

  	
   

  	
  AM1975

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  403051

  	
   

  	
  TF,BDP TAQ FS RR-100-21M13

  	
   

  	
  Big Dye Primer Cycle -21 M13

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  403055

  	
   

  	
  BOX,BDP TAQ FS RR-100-21M13

  	
   

  	
  403051

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  403057

  	
   

  	
  PRTCL,BDP TAQ FS RR KITS

  	
   

  	
  403051

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4312765

  	
   

  	
  TF,GENEAMP GOLD RNA PCR CORE KIT + PROTC

  	
   

  	
  GENEAMP RNA PCR CORE KIT

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4308207

  	
   

  	
  FG,GENEAMP GOLD RNA PCR CORE KIT

  	
   

  	
  4312765

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4310253

  	
   

  	
  PRTCL,GENEAMP GOLD RNA PCR RGNT KITZ

  	
   

  	
  4312765

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4318739

  	
   

  	
  TF,AMPLITAQ GOLD PCR MASTER MIX + PROTO

  	
   

  	
  AmphiTagGold PCR 0.5x

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4316753

  	
   

  	
  FG,AMPLITAQ GOLD MASTER MIX

  	
   

  	
  4318739

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4317621

  	
   

  	
  PRTCL,AMPLITAQ GOLD PCR MASTER MIX

  	
   

  	
  4318739

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4324287

  	
   

  	
  TF,GS120 LIZ SIZE STD

  	
   

  	
  Genscan 120 LIZ Standard

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4322362

  	
   

  	
  FG,GS120 L1Z SIZE STD

  	
   

  	
  4324287

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4340859

  	
   

  	
  TF,4 PK ACTIVATOR 450 ML (401173)

  	
   

  	
  RM, Tetrazole/Acetonitrile

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  401173

  	
   

  	
  FG,TETRAZOLE/ACETONITRILE 450mL

  	
   

  	
  4340859

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
  Need to buy

  4 pack

  Topfill 4340859

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4340860

  	
   

  	
  TF,4 PK CAP A 450 ML (402220)

  	
   

  	
  RM, Acetic Anhydride/Pyridine/Tetrahydro

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  402220

  	
   

  	
  FG,ACETIC ANHYD/PYR/THF 450mL

  	
   

  	
  4340860

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4340861

  	
   

  	
  TF,4 PK CAP B 450 ML (401175)

  	
   

  	
  RM, 1-Mehtylimidazole/Tetrahydrofuran

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  401175

  	
   

  	
  FG,NMI/THF SOLUTION 450mL

  	
   

  	
  4340861

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
  Need to buy

  4 pack

  Topfill 4340861

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4340862

  	
   

  	
  TF,4 PK OXIDIZER 450 ML (401632)

  	
   

  	
  RM, 0.02M Iodine/Water/Pyridine/Tetrahy

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  401632

  	
   

  	
  FG,0.02M IODINE/H20/PYR/THF 450mL

  	
   

  	
  4340862

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
  Need to buy

  4 pack

  Topfill 4340862

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  



 


















 


	
  Internal
  Mfg

  or

  Purchased

  	
   

  	
  AB
  Part

  Number

  	
   

  	
  AB
  Description

  	
   

  	
  Celera
  Description

  	
   

  	
  Order

  Type

  	
   

  	
  Expiry

  	
   

  	
  Leadtime

  (Calendar

  Days)

  	
   

  	
  AB
  Comments

  	
   

  	
  

  

  Celera Comments

  	
   

  	
  Qty ship

  in last 5

  years

  	
   

  	
  Date of
  last

  shipment

  
	
   

  	
   

  	
  4340864

  	
   

  	
  TF,4 PK ACTIVATOR
  180 ML (400606)

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Topfill

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  400606

  	
   

  	
  FG,TETRAZOLE/ACETONITRILE
  180mL

  	
   

  	
  4340864

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
  Need to buy 4
  pack

  Topfill 4340864

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4340865

  	
   

  	
  TF,4 PK CAP A 180
  ML (402222)

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Topfill

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  402222

  	
   

  	
  FG,ACETIC
  ANHYD/PYR/THF 180mL

  	
   

  	
  4340865

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
  Need to buy 4
  pack

  Topfill 4340865

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4340866

  	
   

  	
  TF,4 PK CAP B 180
  ML (400785)

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Topfill

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  400785

  	
   

  	
  FG,NMI SOLUTION
  DNA SYNTHESIS 180mL

  	
   

  	
  4340866

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
  Need to buy 4
  pack

  Topfill 4340866

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4340867

  	
   

  	
  TF,4 PK OXIDIZER
  200 ML (401732)

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Topfill

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  401732

  	
   

  	
  0G,0.02M
  IODINE/H2O/PYR/THF 200mL

  	
   

  	
  4340867

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
  Need to buy 4
  pack

  Topfill 4340867

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4347377

  	
   

  	
  TF,4pk 401272
  TCA/DCM (CH2-C12),2L

  	
   

  	
  RM,
  Trichloroacetic Acid/Dichloromethane

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  401272

  	
   

  	
  FG,TCA/DCM
  (CH2-C12),2L

  	
   

  	
  4347377

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4351176

  	
   

  	
  TF,7500 CHEMICAL
  INSTALL KIT

  	
   

  	
  7500 CHEMICAL
  INSTALL KIT

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4349180

  	
   

  	
  FG,7500 SPECTRAL
  DYE CAL KIT

  	
   

  	
  4351176

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4350584

  	
   

  	
  FG,96 WELL RNASE
  P VERIF PLATE NO PAD

  	
   

  	
  4351176

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4351151

  	
   

  	
  7500 SPECTRAL RED
  DYE CAL KIT

  	
   

  	
  4351176

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4352405

  	
   

  	
  KIT,TAQMAN 18S
  STARTER KIT

  	
   

  	
  4351176

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4363935

  	
   

  	
  TF,BOX OF 10
  BOTTLES POP-7

  	
   

  	
  POP7 Polym.
  3730/3730xl DNA anal

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4335615

  	
   

  	
  FG,BOX OF 5
  BOTTLES POP7

  	
   

  	
  4363935

  	
   

  	
  OTS

  	
   

  	
  ETU

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  4379580

  	
   

  	
  TF,METHYlSEQR
  BISULFITE CONVERSION KIT

  	
   

  	
  methyl SEQr

  	
   

  	
  OTS

  	
   

  	
  NA

  	
   

  	
   

  	
   

  	
  Topfill.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4374960

  	
   

  	
  FG,METHYLSEQR
  REAGENT KIT

  	
   

  	
  4379580

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4374959

  	
   

  	
  FG,METHYLSEQR
  PURIFICATION COLUMNS

  	
   

  	
  4379580

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Purchased

  	
   

  	
  4374710

  	
   

  	
  PRTCL,METHYLSEQR
  BISULFITE SQNCNG

  	
   

  	
  4379580

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
  EXHIBIT
  A.2 - RAW MATERIALS

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
  [**]  

  [**]  

  [**]  

  [**]

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  



 


	
   

  	
   

  	
  AB
  Part 

  Number

  	
   

  	
  AB
  Description

  	
   

  	
  Description

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Internal Mfg

  	
   

  	
  4344411

  	
   

  	
  FG,NED
  AMIDITE,1.0g

  	
   

  	
  RM, NED AMIDITE
  (1 gram)

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Celera
  is only user.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4344416

  	
   

  	
  FG,VIC-2 AMIDITE,
  1.0g

  	
   

  	
  RM, VIC - 2
  AMIDITE (1 gram)

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Celera
  is only user.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4344670

  	
   

  	
  FG,HEX NHS ESTER
  100MG

  	
   

  	
  HEX NHS Ester

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Celera
  is only user.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4345702

  	
   

  	
  FG,DMT-PEG
  AMIDITE, 745mG

  	
   

  	
  PEO
  Phosphoramidite

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Celera
  is major user.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4346490

  	
   

  	
  FG,VIC AMIDITE
  200mg

  	
   

  	
  RM, VIC Amidite

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Celera
  is only user.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4346506

  	
   

  	
  FG,NED AMIDITE
  200mg

  	
   

  	
  RM, NED Amidite

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  Celera
  is only user.

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  



 


	
   

  	
   

  	
  Part Number

  	
   

  	
   

  	
   

  	
  Description

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Additional
  Items

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4336701

  	
   

  	
  BTL,5X SEQ BUFFER
  LARGE

  	
   

  	
  BigDye® Terminator
  v1.1 & v3.1 5X Sequencing

  Buffer (233ml)

  	
   

  	
  OTS

  	
   

  	
  ETS

  	
   

  	
   

  	
   

  	
  BigDye®

  Terminator v1.1

  & v3.1 5X

  Sequencing

  Buffer (233ml)

  	
   

  	
  Celera

  PN 5002298/

  Need for BDT

  	
   

  	
  [**]

  	
   

  	
  [**]

  
	
  Internal Mfg

  	
   

  	
  4346492

  	
   

  	
  FG,6-FAM AMIDITE
  200mg

  	
   

  	
  RM, 6 - FAM
  Amidite v.2

  	
   

  	
  MTO

  	
   

  	
  ETS

  	
   

  	
  [**]

  	
   

  	
  RM, 6 - FAM

  Amidite v.2

  	
   

  	
  Celera

  PN 5000134

  	
   

  	
  [**]

  	
   

  	
  [**]

  







[**]
indicates material that has been omitted pursuant to a request for confidential
treatment. The omitted material has been filed separately with the Securities
and Exchange Commission.


 














 


Exhibit B


 


Instruments


 


ABI Prism 310


ABI Prism 3100


ABI Prism 3100
Avant


ABI Prism 3130


ABI Prism 3130
xl


ABI Prism 3730
xl